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ABSTRACT
TRANSCRIPTIONAL CONTROL AND POPULATION DYNAMICS
+

OF ANTIVIRAL CD8 T CELL RESPONSES

Michael A. Paley

E. John Wherry, Ph.D.

Cytotoxic lymphocytes are central components of cellular immune responses to
intracellular pathogens and malignancy. The transcriptional programs that support
proper population dynamics for lifelong immunity are incompletely understood. Two Tbox transcription factors, T-bet and Eomesodermin (Eomes), have critical roles in the
development of natural killer cells and the differentiation of CD8+ T cells in response to
acutely resolved infections. In both cases, these two factors support distinct but
complementary cellular populations. In this thesis, we first used a recently generated
reagent to examine and separate cellular populations with differential Eomes expression.
We found that, while Eomes expression does not identify effector CD8+ T cells with
enhanced cytotoxic potential, early Eomes expression does correlate with more efficient
formation of long-lived, self-renewing central memory CD8+ T cells. This validated tool
was then employed in our investigation into the population dynamics of CD8+ T cell
responses during a chronic viral infection. While memory lymphocytes maintain lifelong
immunity by slow self-renewal, chronic infections strain the regenerative capacity of
antiviral T lymphocyte populations, leading to failure in long-term immunity. The cellular
and molecular events controlling the regenerative capacity during chronic infection,
iv

however, are unknown. We demonstrate that two distinct states of virus-specific CD8+ T
cells exist in chronically infected mice and humans. The opposing properties of renewal
and differentiation of these CD8+ T cell populations are supported by the differential
expression of T-box transcription factors, which cooperatively maintain the pool of
antiviral CD8+ T cells during chronic viral infection. T-bethi cells have low intrinsic
turnover but proliferate in response to persisting antigen, giving rise to Eomeshi terminal
progeny. Genetic elimination of either subset results in failure to control chronic infection,
suggesting that imbalance in differentiation and renewal could underlie the collapse of
immunity in humans with chronic infections. Furthermore, this work demonstrates new
roles for T-bet and Eomes in CD8+ T cells regarding self-renewal and terminal
differentiation, highlighting how T-box transcription factors can operate in exquisitely
context-dependent manners.
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CHAPTER 1: Introduction
1.1 Viral challenges to human health
Viral infections are a common challenge to the mammalian immune system.
While many viral infections induce minimal disease in immunocompetent individuals,
some viruses pose significant threats to worldwide health. For example in the United
States, seasonal influenza averages 20,000 deaths every year as a result of acute
infection (CDC, 2010). In contrast, other viruses, such as human immunodeficiency virus
(HIV) or hepatitis C virus (HCV), establish a chronic infection and elicit disease over the
ensuing years, each averaging 15,000 annual deaths (CDC, 2011; Ly et al., 2012).
Therapies against HCV, while potentially curative, display low efficacy (Fried et al., 2002;
Manns et al., 2001; McHutchison et al., 1998; McHutchison et al., 2009; Welsch et al.,
2012). In contrast, current medical interventions for HIV infection are not geared towards
viral elimination, but rather are limited to reducing viral replication (Piacenti, 2006).
Consequently, investigators continue to pursue other approaches that have the potential
to synergize with or potentially replace current medical therapies. In particular,
prophylactic or therapeutic interventions based on antiviral immune responses have
demonstrated potential in this regard (Barber et al., 2006; Buchbinder et al., 2008; Diskin
et al., 2011; Hansen et al., 2011; Rerks-Ngarm et al., 2009; Scheid et al., 2009; Scheid
et al., 2011; Velu et al., 2009; Wei et al., 2010; Zhou et al., 2010). Nevertheless, it
remains to be defined which components of the adaptive immune system are required to
generate effective and broad immunity to each of these individual pathogens.
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1.2 Adaptive immune responses
While humoral immunity can provide an effective obstacle to establishment of a
viral infection through antibody-mediated neutralization, clearance of an invading
microbe depends on an effective response by the cellular arm of the adaptive immune
system. In particular, CD8+ T cells fulfill a critical role due to their ability to recognize
virally infected cells. This recognition is mediated by interactions between the T cell
receptor (TCR) and components of degraded foreign viral proteins (8-10 amino acids in
length) presented by the major histocompatibility complex (MHC) (Rock and Goldberg,
1999). In this way, CD8+ T cells can recognize virally infected cells that may not display
outward signs of infection.
The importance of CD8+ T cell responses in controlling viral replication and
subsequent disease has been implicated through examination of immunodeficient
patients with susceptibility to viral infection and through genome-wide association
studies after viral infection. For example, genetic mutations in the effector molecule
perforin (discussed below) can impair both CD8+ T cell function and immune clearance
of viral infection, leading to the inflammatory disorder termed hemophagocytic
lymphohistiocytosis (HLH) (Jordan et al., 2004; Kogawa et al., 2002; Pachlopnik Schmid
et al., 2009; Stepp et al., 1999). In addition, mutations in the receptor for IFN-gamma
(discussed below), a major effector cytokine of CD8+ T cells, have been associated with
severe viral infections, including herpes, parainfluenza, and respiratory syncytial viruses
(Dorman et al., 1999). Similar to inherited or spontaneous mutations that lead to
immunodeficiencies early in life, acquired immunosupression also illustrates the
importance of CD8+ T cells in response to viral infections. For example,
immunocompromised individuals due to HIV infection are at risk for clinical reactivation
2

of JC polyomavirus and subsequent progressive multifocal leukoencephalopathy (PML).
In this setting, disease resolution was strongly associated with detectable antiviral CD8+
T cell responses (Du Pasquier et al., 2004). Thus, genetically impaired or
immunologically poor CD8+ T cell responses have been suggested to lead to a variety of
human disease states after viral infection.
In parallel to these “experiments of nature,” genomic sequencing of
polymorphisms has provided insight into individual genes that modulate control of or
susceptibility to viral infection. For example during HIV infection, while several genes
associated with co-receptor binding and viral entry, such as CCR5 and beta chemokines
(CCL3-CCL5), have been linked to superior clinical outcomes, a number of MHC alleles
have been associated with improved control of HIV replication, consistent with the
hypothesis that CD8+ T cell responses are an essential component of the antiviral
response (Chapman and Hill, 2012). Similarly, MHC alleles have also been associated
with clearance or susceptibility to hepatitis B virus (HBV) (He et al., 2006) or enterovirus
infection (Chang et al., 2008). Thus, the ability of CD8+ T cells to recognize virally
infected target cells is associated with clinical protection against viral infection.

1.3 CD8+ T cell responses
Maintenance of virus-specific CD8+ T cell responses poses a unique challenge.
Unlike other tissues with high rates of cellular replacement from long-lived progenitors,
the CD8+ T cells that comprise antiviral responses may be genetically unique due to
rearrangement of the TCR locus during thymic development (Koch and Radtke, 2011).
In addition, these cells may have a low probability of replacement after age-associated
thymic involution (Lynch et al., 2009). As a consequence, antiviral CD8+ T cells illustrate

3

a heightened tension between renewal (to preserve the unique TCR rearrangement) and
terminal differentiation (to effectively mount an antiviral response).
1.3.1 Initiation of antiviral CD8+ T cell responses
After exposure to antigen, a naive CD8+ T cell initiates a phase of proliferation
and differentiation to generate a large population of antiviral effector cells (Butz and
Bevan, 1998; Murali-Krishna et al., 1998). CD8+ T cells mediate viral clearance through
a variety of mechanisms. The most well-known effector function of “killer” T cells is the
destruction of virally infected target cells. This cytotoxicity can be mediated by at least
two separate mechanisms. The first is release of perforin, which forms a pore in the
target cell membrane. The perforin pore leads to osmotic imbalances (Persechini et al.,
1990) and allows for entry of granzymes into the target cell inducing cell death (Trapani
and Smyth, 2002). The second mechanism is mediated by the expression of Fas ligand
and subsequent activation of the Fas death receptor pathway, leading to programmed
cell death of the target cell (Kagi et al., 1994a; Kagi et al., 1994b; Lowin et al., 1994;
Trapani and Smyth, 2002). In addition to direct cytotoxicity, CD8+ T cells also contribute
to viral clearance through the release of proinflammatory cytokines, such as MIP-1alpha,
IL-2, TNF-alpha, and IFN-gamma (Cocchi et al., 1995; Guidotti and Chisari, 1996). In
particular, IFN-gamma plays a critical role in sensitizing target cells to cytolysis,
enhancing antimicrobial activities of the innate immune system, and interfering with
components of the viral life cycle (Schroder et al., 2004).
1.3.2 Generation of lifelong CD8+ T cell memory after acutely resolved infections
The population of terminal effector cells is short-lived and rapidly cleared after
pathogen clearance (Joshi et al., 2007; Kaech et al., 2003; Murali-Krishna et al., 1998).
A second population, however, persists after this contraction phase and matures into the
4

long-lived memory population that supports immunity in the case of pathogen reexposure. A number of events have been suggested to influence the development of this
memory precursor population, including exposure to inflammatory signals (Joshi et al.,
2007), such as CpG (Pham et al., 2009), IL-2 (Manjunath et al., 2001; Pipkin et al.,
2010), and IL-12 (Takemoto et al., 2006), as well as asymmetric cell division (Chang et
al., 2007).
The events that regulate the evolution from memory precursors to long-lived
memory cells, however, are less well understood. After the contraction phase, the initial
surviving population of virus-specific cells has low expression of lymphoid homing
markers (CD62L and CCR7) and resembles an effector memory T cell population
(Wherry et al., 2003b). Over time, this population matures into a central memory pool
that effectively homes to lymphoid organs and homeostatically self-renews (Wherry et
al., 2003b). What signals regulate this maturation process is not well understood.
One pathway that is known to influence the rate of memory maturation is the
mammalian target of rapamycin (mTOR) pathway. Lose dose treatment with an inhibitor
of the mTOR signaling cascade not only enhances the generation of memory precursor
CD8+ T cells during the expansion phase, but also independently accelerates the
memory precursor maturation towards central memory (Araki et al., 2009). The ability of
rapamycin to enhance memory differentiation has been suggested to be due to changes
in the expression of T-box transcription factors (discussed below) (Rao et al., 2010).
1.3.3 Maintenance of lifelong CD8+ T cell memory to acutely resolved infections
Once formed, memory T cells undergo slow homeostatic division in response to
the homeostatic cytokines IL-7 and IL-15 (Becker et al., 2002; Goldrath et al., 2002; Tan
5

et al., 2002). This division is non-hierarchical as each long-lived memory cell has an
equal probability of entering division (Choo et al., 2010) and has been suggested to
predominantly occur in the bone marrow (Becker et al., 2005). In contrast, once memory
cells encounter their cognate antigen, they proliferate and differentiate, giving rise to a
population of short-lived cells that contribute to the anti-pathogen response (Ciocca et
al., 2012; Dutton et al., 1998; Wherry et al., 2003b). At the same time, however, these
activated memory cells renew the long-lived memory pool to ensure immunity in the
event of future infection (Ciocca et al., 2012; Wherry et al., 2003b). In this way, memory
T cells can effectively provide for lifelong protection against acutely resolved infections.
1.3.4 Responses to persistent antigen and inflammation: CD8+ T cell exhaustion
Chronic infections with high rates of pathogen replication as well as malignancy
pose a different and perhaps more difficult challenge for maintaining anti-pathogen or
anti-tumor responses. In contrast to acute infection, where the immune system returns to
a state of quiescence after pathogen clearance, chronic infections and malignancy lead
to sustained antigen and inflammation. How CD8+ T cells maintain such responses over
years or decades has appeared paradoxical.
CD8+ T cell responses to chronic viral infection in mice and humans have been
characterized by their poor proliferative responses to in vitro antigenic stimulation
(Migueles et al., 2002; Wherry et al., 2004; Zajac et al., 1998,Brenchley, 2003 #1353).
Thus, it was possible that a prolonged antiviral (or anti-tumor) response was maintained
by long-lived “exhausted” cells that have low rates of proliferation and cell turnover.
Other investigators, however, have observed that exhausted CD8+ T cells have elevated
rates of proliferation and cell turnover. For example, CD8+ T cells from chronically
infected humans and mice display increased rates of apoptosis (Blackburn et al., 2010;
6

Gougeon et al., 1996; Lewis et al., 1994; Meyaard et al., 1992) which are matched by an
extensive proliferative history (Brenchley et al., 2003), likely a result of high rates of cell
turnover and in vivo proliferation (Hellerstein et al., 1999; Hellerstein et al., 2003;
McCune et al., 2000; Sachsenberg et al., 1998; Shin et al., 2007). How to reconcile
these discordant findings has remained unclear. Chapter 3 of this thesis will provide
data to define the population dynamics of exhausted CD8+ T cell responses.
A second feature of CD8+ T cell exhaustion is a reduction in effector functionality,
such as cytotoxic potential and proinflammatory cytokine expression (Wherry, 2011).
This dysfunction is associated with the upregulation of a variety of surface molecules,
termed inhibitory receptors, which limit cytotoxic lymphocyte responses. Higher
expression of a single inhibitory receptor (Blackburn et al., 2010; Day et al., 2006;
Nakamoto et al., 2008) or enhanced co-expression of multiple of inhibitory receptors
(Blackburn et al., 2009; Jin et al., 2010; Matsuzaki et al., 2010; McMahan et al., 2010;
Nakamoto et al., 2009; Sakuishi et al., 2010) correlates with reduced CD8+ T cell effector
function. In addition, blockade of a single (Barber et al., 2006; Brahmer et al., 2012; Day
et al., 2006; Nakamoto et al., 2008; Raziorrouh et al., 2010; Topalian et al., 2012; Velu et
al., 2009) or a combination (Blackburn et al., 2009; Jin et al., 2010; Matsuzaki et al.,
2010; McMahan et al., 2010; Nakamoto et al., 2009; Sakuishi et al., 2010; Zhou et al.,
2011) of inhibitory receptors restores CD8+ T cell function and leads to improved viral or
tumor control.
In addition to the expression of inhibitory receptors, immunoregulatory cytokines
have also been implicated in the development of viral persistence and CD8+ T cell
exhaustion. In particular, deletion or blockade of IL-10 (Brooks et al., 2008; Brooks et al.,
2006) or TGF-beta (Tinoco et al., 2009) has demonstrated these cytokines impede viral
7

elimination. Along with restoration of effector functions, most therapeutic interventions
are associated with improved proliferation and expansion of antiviral or anti-tumor CD8+
T cell responses. Thus, whether the beneficial effects of therapeutic intervention are a
result of enhanced quality of CD8+ T cell effector functions, expansion of the total CD8+
T cell population, or a combination thereof remains to be determined. Chapter 3 will
provide a framework to understand how such interventions might influence the
population dynamics of the CD8+ T cell response.

1.4 T-box transcription factors
Specification of differential cellular function and behavior is programmed through
a network of transcriptional regulators. The family of T-box transcription factors, named
after the founding member Brachyury (T), contributes to this specification during a
diverse set of developmental processes, including trophoblast, limb, brain, heart, and
immune cell differentiation (Naiche et al., 2005). The T-box family is defined by a
conserved DNA binding domain that has been suggested to prefer the DNA consensus
sequence TCACACCT (Naiche et al., 2005).
1.4.1 Activity of T-box transcription factors is context-dependent
T-box transcription factors regulate their target genes through a variety of
mechanisms. T-box factors appear to be capable of both activation and repression of
target genes. This differential activity appears to be dependent, in part, on other nuclear
factors, such as histone methyltransferases (Lewis et al., 2007), suggesting that T-box
factors may operate in a context-dependent manner. In support of this hypothesis,
introduction of transcriptional repressors belonging to the Ripply or BTB-POZ family
converts the activating activity of Tbx24 and T-bet (Tbx21) into repressive activity,
respectively (Kawamura et al., 2008; Oestreich et al., 2011; Oestreich et al., 2012).
8

Furthermore, despite the apparent conserved binding affinity to the DNA consensus
sequence and equivalent recruitment of histone methyltransferases by multiple family
members, T-box factors still maintain cell-specific activity (Lewis et al., 2007). Thus, Tbox factors may be highly dependent on the co-expressed transcriptional network in
order to appropriately regulate target genes.
Oppositional activity of two related T-box family members was first hypothesized
to occur between Tbx4 and Tbx5 in limb development. In the developing embryo, Tbx4
and Tbx5 are expressed in the hindlimb and forelimb, respectively. Mutations in Tbx4
lead to a human syndrome with lower limb deformities (Bongers et al., 2004), while
mutations in Tbx5 lead to Holt-Oram syndrome with upper limb malformations (Basson
et al., 1997; Li et al., 1997), suggesting that differential T-box factor expression
conferred differential limb fate. Consistent with this hypothesis, inappropriate ectopic
expression of Tbx4 or Tbx5 led to the development of hindlimbs or forelimbs,
respectively, or features thereof (Rodriguez-Esteban et al., 1999; Takeuchi et al., 1999).
Thus, two T-box factors may initiate and maintain distinct transcriptional programs within
similar or analogous cell types.
1.4.2 T-box factors regulate self-renewal and differentiation
While T-box transcription factors have a variety of roles during embryogenesis
and development, several family members also regulate tissue homeostasis in the adult
organ. For example, Tbx1 regulates the renewal of long-lived progenitors in the hair
follicle. Deletion of Tbx1 leads to an accelerated decline of these follicle stem cells after
repeated regenerative stress (Chen et al., 2012). Other T-box family members regulate
the development of terminally differentiated cells. For example, Eomesdermin (Eomes)
supports the amplification and differentiation of neurons in the embryonic subventricular
9

zone (Arnold et al., 2008) and the adult dentate gyrus (Hodge et al., 2012). Thus, T-box
factors can support either long-lived, quiescent progenitors or short-lived, terminally
differentiated progeny.
1.4.3 T-box factors regulate antiviral immunity
The two T-box factors that are expressed in immune cells are T-bet and
Eomesodermin (Eomes). These two factors belong to the same T-box subfamily, which
they share with T brain 1 (Tbr1) (Szabo et al., 2000). T-bet and Eomes share 74%
identity in the T-box domain, but only 25% identity in the flanking C-terminal and Nterminal regions (Pearce et al., 2003). While T-bet is expressed in a variety of immune
cells associated with an antiviral Type 1 response (Lugo-Villarino et al., 2003; Sullivan et
al., 2003; Szabo et al., 2000; Szabo et al., 2002; Townsend et al., 2004; Wang et al.,
2012), Eomes expression is largely restricted to cytotoxic lymphocytes (Pearce et al.,
2003) and potentially CD4+ T cells engaged in a Type 1 response (Qui et al., 2011; Suto
et al., 2006; Yagi et al., 2010; Yang et al., 2008). One exception, however, may be a
specific subpopulation of TH2 CD4+ T cells that express IL-5 (Endo et al., 2011).
1.4.4 T-bet and Eomes in Natural Killer cells
Natural killer (NK) lymphocyte development is initiated in the bone marrow with
the generation of the NK precursor (NKp). Further progression through development to
an intermediate stage is marked by the upregulation of NK cell antigens such as NK1.1
and NKp46 as well as the death ligand TRAIL. While developmental arrest can occur at
this stage, full NK cell maturation is associated with a proliferative burst and battery of
phenotypic changes, including loss of TRAIL expression, upregulation of the
inhibitory/activating Ly49 receptor family, induction of the integrins CD11b and CD49b,
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and downmodulation of the costimulatory molecule CD27 (Gordon et al., 2012;
Yokoyama et al., 2004).
T-bet and Eomes are both expressed during this process; however, the exact
role these factors play in NK cell development has recently been illuminated. In the
absence of Eomes, NK cells arrest at the intermediate stage of differentiation, displaying
expression of TRAIL with minimal CD49b expression. Eomes is also necessary for
maintaining the stable program of fully mature NK cells, since temporal deletion of
Eomes in CD49b+ NK cells leads to the loss of CD49b expression and the reacquisition
of TRAIL expression (Gordon et al., 2012). Thus, Eomes plays a critical role specifically
in this second stage of NK maturation.
Unlike Eomes, T-bet appears to regulate earlier developmental steps. In the
absence of T-bet, NK cells appear to have an accelerated developmental progression
and lack cells that arrest at the intermediate TRAIL+ stage. In fact, temporal deletion of
T-bet in intermediate NK cells leads to induction of Eomes expression and progression
to a mature stage. Without either T-box factor, however, NK development does not
progress past the NKp stage (Gordon et al., 2012). Thus, T-bet and Eomes appear to
provide sequential specification during NK cell development.
1.4.5 T-bet and Eomes in CD8+ T cells during acute infection
In response to an acutely resolved infection, CD8+ T cells generate two
populations of antiviral cells: short-lived, terminally differentiated effectors and long-lived,
self-renewing memory. T-bet and Eomes appear to regulate the function, formation, and
survival of both these populations. During the initial expansion after antigenic
stimulation, T-bet and Eomes redundantly support cytotoxic effector programming
11

(Intlekofer et al., 2008; Zhu et al., 2010). This is likely a result of direct binding and
transactivation of genes encoding cytotoxic molecules, such as perforin and granzyme
B, and inflammatory cytokines, such as interferon gamma (Intlekofer et al., 2005 CruzGuilloty, 2009 #807; Pearce et al., 2003; Pipkin et al., 2010; Townsend et al., 2004).
Loss of both transcription factors leads to ineffective antiviral responses and aberrant
differentiation to a Type 17 response (Intlekofer et al., 2008). T-bet and Eomes also
redundantly support CD8+ T cell longevity through positive regulation of the beta chain of
the IL-15 receptor, CD122. In particular, Eomes directly binds to the CD122 locus and
activates gene expression (Intlekofer et al., 2005).
T-bet and Eomes, however, also have opposing or alternative roles in CD8+ T
cell responses to acutely resolved infection. Formation of terminally differentiated
effector cells is dependent on the activity of T-bet (Intlekofer et al., 2007; Joshi et al.,
2007) but unaffected by the loss of Eomes (Banerjee et al., 2010). The expression of Tbet during this process is regulated by environmental cues, such as CD4+ T cell help
(Intlekofer et al., 2007), IL-12 signaling (Takemoto et al., 2006), and potentially other
inflammatory signals (Joshi et al., 2007). The enhancement of the terminally
differentiated population occurs at the expense of the memory precursor population
(Intlekofer et al., 2007; Joshi et al., 2007; Takemoto et al., 2006).
In contrast, Eomes supports the development or maintenance of long-lived, selfrenewing memory. Eomes expression is enriched in the memory pool after several
months post viral clearance (Banerjee et al., 2010; Intlekofer et al., 2005) and genetic
deletion of Eomes leads to a gradual decline in the memory population (Banerjee et al.,
2010). Eomes deficient memory cells also display poor expansion after antigenic
challenge (Banerjee et al., 2010). The impaired maintenance is thought to be secondary
12

to poor homing to the bone marrow for homeostatic proliferation. Thus, T-bet and Eomes
act redundantly to initiate effector programming, yet support alternative CD8+ T cell
fates. Chapter 2 of this thesis will extend our understanding of when and how Eomes
supports and directs the differentiation CD8+ T cells in response to acute viral infection.
1.4.6 T-bet in CD8+ T cells during chronic infection
The role for T-box factors in chronic viral infection is quite distinct from that of
acutely resolved infection. Based on T-bet’s essential role in the formation of terminal
effectors during the initial expansion, one might predict that T-bet expression would
remain elevated as CD8+ T cells mount a prolonged antiviral response. After contraction
of the short-lived population, however, T-bet expression in both mice (Kao et al., 2011)
and humans (Hersperger et al., 2011; Ribeiro-Dos-Santos et al., 2012) is downregulated during chronic infection. The reduced expression of T-bet correlates with CD8+
T cell dysfunction, including lower perforin expression (Hersperger et al., 2011; RibeiroDos-Santos et al., 2012), poor viral control (Hersperger et al., 2011), and higher
inhibitory receptor expression (Kao et al., 2011). Furthermore, genetic reduction in T-bet
expression leads to enhanced inhibitory receptor expression, reduced cytokine
expression, and an inability to sustain antiviral CD8+ T cell responses (Kao et al., 2011).
Thus, higher T-bet expression is associated with more effective antiviral responses to
chronic infections. Chapter 3 in this thesis will extend our understanding of the manner
in which T-bet sustains antiviral responses during chronic viral infection.
1.4.7 Eomes in CD8+ T cells during chronic infection
Based on Eomes’ regulation of effective cytotoxic effector programming and
maintenance of long-lived, protective memory, one could imagine that dysfunctional
responses to chronic viral infections would be associated with lower Eomes expression.
13

Microarray analysis, however, has suggested that Eomes is elevated in exhausted CD8+
T cells (Wherry et al., 2007). Chapter 3 in this thesis will investigate the role for Eomes
in this setting.

1.5 The Lymphocytic Choriomeningitis Model of Viral Infection
Lymphocytic Choriomeningitis Virus (LCMV) is a robust model of viral infection.
Identified in 1934 by Charles Armstong (Beeman, 2007), LCMV is a negative sense,
single stranded RNA virus belonging to the Arenaviridae family. Viral entry is mediated
by GP1 protein of LCMV binding to alpha-dystroglycan on host cells, allowing for multiorgan dissemination (Borrow and Oldstone, 1992; Cao et al., 1998). Clearance of viral
infection requires an effective CD8+ T cell response (Jamieson et al., 1987; Moskophidis
et al., 1987). Defects in CD8+ T cell effector functions have been demonstrated to impair
viral clearance. For example, loss of IFN-gamma, Fas receptor activation, or perforin
prevents effective viral control in LCMV-infected mice (Klavinskis et al., 1989; Leist et al.,
1989; Nansen et al., 1999; Rode et al., 2004; Wille et al., 1989). As a result, LCMV
provides an effective model to test CD8+ T cell mediated viral control.
1.5.1 Acutely resolved LCMV infection
The initial strain of LCMV, named Armstrong after its discoverer Charles
Armstrong (Beeman, 2007), initiates an acutely resolved infection. In adult mice, this
virus replicates predominantly in the spleen, liver, and kidney and is normally cleared
within 10 days with no manifestation of disease (Wherry et al., 2003a). LCMV Armstrong
elicits potent adaptive immune responses that provide effective protection to
rechallenge. Chapters 2 & 3 will use LCMV Armstrong to model CD8+ T cell responses
to an acutely resolved viral infection.
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1.5.2 Chronic LCMV infection
In contrast to infection of adult mice, introduction of LCMV Armstong to neonatal
mice leads to the development of a carrier state. These mice develop poor adaptive
immune responses and are persistently infected with LCMV. A variant of LCMV
Armstrong (clone 13) was isolated from the spleen of a carrier mouse. This variant was
found to have acquired the capacity to persist in the adult host and establish a chronic
infection (Ahmed et al., 1984). The ability of LCMV clone 13 to persist in the adult host
was a result of two specific point mutations: one in the viral polymerase and one in the
viral glycoprotein (Matloubian et al., 1993; Matloubian et al., 1990; Salvato et al., 1991;
Sullivan et al., 2011). The mutation in the viral polymerase increases the polymerase
activity and accelerates viral replication. The mutation in the viral glycoprotein increases
the affinity of the viral glycoprotein for its receptor alpha-dystroglycan and broadens the
tropism of the virus. Together, these two mutations are sufficient to convert LCMV from
an acutely resolved infection to a chronic infection (Sullivan et al., 2011). Infection of
immunocompetent mice with LCMV clone 13 leads to systemic viral replication with
viremia lasting 2-3 months and lifelong viral reservoirs in the kidney and the brain
(Wherry et al., 2003a). One benefit of the comparison between Armstrong and clone 13
is that the adaptive immune recognition between these two variants is identical. Chapter
3 of this thesis will employ this comparison to investigate transcriptional differences that
arise due to viral persistence. Furthermore, Chapter 3 will use LCMV clone 13 as a
robust model to investigate CD8+ T cell responses to viral infection.
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CHAPTER 2: Fluorescent reporter reveals insights into
Eomesodermin biology in cytotoxic lymphocytes
2.1 Introduction:
Cytotoxic lymphocytes play important roles in anti-viral and anti-tumor immune
responses. Two major effector functions of NK and CD8+ T cells are the release of proinflammatory cytokines and the killing of virally infected or transformed target cells via
the perforin and granzyme pathway. These pathways are regulated by several
transcription factors, including Eomesodermin (Eomes). However, Eomes has also been
reported to regulate other essential features of cytotoxic cells. As a result, the relative
importance of Eomes activity on effector functions versus differentiation remains
obscure.
Eomes supports a variety of differentiation events, ranging from mesoderm
formation in the developing embryo (Russ et al., 2000) to lymphocyte differentiation in
response to infection (Hertoghs et al., 2010; Intlekofer et al., 2008; Intlekofer et al.,
2005). In the hematopoetic system, Eomes has been reported to direct the differentiation
of multiple lymphocyte subsets. For example, Eomes plays an important role in
formation and maintenance of mature TRAIL-DX5+ NK cells (Gordon et al., 2012;
Intlekofer et al., 2005; Tayade et al., 2005). In CD8+ T cells, Eomes has pleiotropic roles,
supporting the developmental program of both effector (Intlekofer et al., 2008) and
memory (Banerjee et al., 2010; Intlekofer et al., 2005) T cells.
Eomes was identified in cytotoxic lymphocytes owing to its role in regulating
expression of several effector molecules, e.g. IFN-γ, perforin, and granzyme B (Pearce
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et al., 2003). Correspondingly, Eomes expression has been associated with enhanced
CD8+ T cell cytotoxicity (Gao et al., 2005; Hegel et al., 2009; Hinrichs et al., 2008;
Intlekofer et al., 2005; Pipkin et al., 2010; Rao et al., 2010; Tao et al., 2007) and antiviral (Intlekofer et al., 2008) and anti-tumor (Atreya et al., 2007; Gao et al., 2005;
Hinrichs et al., 2008; Rao et al., 2010; Tao et al., 2007; Zhu et al., 2010) responses.
Eomes expression has also been reported in cytotoxic CD4+ T cells and is essential for
expression of granzyme B in these cells (Qui et al., 2011). Thus, Eomes is thought to be
integral to the program of cytotoxic gene expression in multiple lymphocyte lineages and
may provide an opportunity for therapeutic targeting.
Consequently, CD8+ T cells that are induced or programmed to express high
levels of Eomes would be predicted to have increased expression of effector molecules
and enhanced lytic potential. Indeed, Eomes expression is heterogeneous within CD8+ T
cell populations, displaying a large dynamic range (Banerjee et al., 2010; Gordon et al.,
2011). Whether CD8+ T cells with high Eomes expression produce more cytotoxic
molecules and therefore exhibit higher cytolytic capacity than Eomes non-expressers
has not been examined.
Eomes expression is also particularly important for the maintenance of central
memory CD8+ T cells (Banerjee et al., 2010), in part through its transcriptional regulation
of the gene encoding IL-15Rβ (CD122), which enhances IL-15 responsiveness
(Intlekofer et al., 2005). However, whether expression of Eomes during the expansion
phase of the CD8+ T cell response is associated with improved formation or survival of
central memory cells has not been determined. The initial Eomes reporter mouse
required the addition of substrate in order to generate transient fluorescence (Intlekofer
et al., 2005; Russ et al., 2000). A subsequent fluorescent protein-based construct with
17

spontaneous fluorescence grossly correlated with Eomes expression in the developing
embryo (Kwon and Hadjantonakis, 2007), yet displayed incomplete fidelity in the
developing brain (Arnold et al., 2009; Kwon and Hadjantonakis, 2007). A novel Eomes
fluorescent reporter mouse, however, where GFP is expressed from the Eomes locus in
lieu of Eomes more effectively paralleled Eomes expression (Arnold et al., 2009). Here,
we report the validation and use of this Eomesgfp targeted allele in the study of Eomes
gene expression in NK and CD8+ T cells.
In CD8+ T cells, we were able to separate Eomes expressors (GFP+) from Eomes
non-expressors (GFP-) by flow cytometry and address specific cytotoxic capacity of
these subsets. Unexpectedly, Eomes expression was not associated with enhanced lytic
potential in effector CD8+ T cells; however, early Eomes expression did correlate with
improved central memory formation. Furthermore, examination of Eomesgfp expression
in the absence of Eomes protein suggested that Eomes+ central memory CD8+ T cells
may be dependent on Eomes expression for persistence. Lastly, reporter activity in
Eomes-deficient NK cells allowed for the identification of putative intermediates in NK
cell development that are primed for full maturation into TRAIL-DX5+ NK cells. Thus, the
Eomesgfp targeted allele should provide a novel opportunity to further understand the role
of Eomes in cytotoxic lymphocytes.

2.2 Methods
2.2.1 Mice and Infection:
All animals were housed at the University of Pennsylvania (Philadelphia, PA).
Experiments were performed in accordance with protocols approved by the University of
Pennsylvania Institutional Animal Care and Use Committee. Eomesgfp/+ mice have been
18

described previously (Arnold et al., 2009). To study Eomes GFP reporter activity during
Fas deficiency, Eomesgfp/+ mice were mated to Faslpr/lpr mice. To study Eomes GFP
reporter activity in the absence of Eomes protein, Eomesgfp/+ mice were mated to
Eomesflox/flox mice with or without CD4-Cre or Vav-Cre. To study Eomesgfp expression
during anti-viral responses, mice were infected with 2 x 105 PFU of lymphocytic
choriomenigitis virus (LCMV) Armstrong strain by i.p. injection. For some experiments,
Eomesgfp/+ mice were also mated to P14 TCR-Tg mice to generate P14 Eomesgfp/+ mice.
5 x 10^4 Eomesgfp/+ P14 CD8+ T cells (CD90.1) were transferred to WT B6 mice
(CD90.2) 1 day prior to infection with LCMV Armstrong.
2.2.2 Flow cytometry, division dye labeling, and real-time PCR:
Surface and intracellular staining were performed as described previously
(Gordon et al., 2011; Intlekofer et al., 2008). Antibodies used for flow cytometry were
purchased from BD Biosciences (CD3, CD4, CD8, CD19, CD27, CD44, CD62L, CD122,
DX5, NK1.1; San Jose, CA) or eBioscience (CD45.1, CD45.2, CD90.1, CD107a, CD127,
Eomes, KLRG1, TRAIL; San Diego, CA). Intracellular staining for GFP was performed
with polyclonal anti-GFP (eBioscience) followed by goat anti-rabbit Alexa Flour 488
secondary (Invitrogen, Carlsbad, CA). Data were collected on a BD LSRII (BD
Biosciences) and analyzed with FlowJo software (Tree Star, Ashland, OR). Cell sorting
was performed using a BD Aria II (BD Biosciences). For indicated experiments, sorted
cells were subsequently labeled with CellTrackerTM Violet (Invitrogen) according to
manufacturer’s instructions. qRT-PCR was carried out as previously described
(Intlekofer et al., 2008). Target gene probes were purchased from Applied Biosystems
(Foster City, CA).
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2.2.3 Cytotoxicity assay:
Splenocytes from wild-type CD45.1 mice were labeled with two different
concentrations (50 nM = “dim” or 2 µM = “bright”) of carboxyfluorescein diacetate
succinimidyl ester (CFSE) (Invitrogen). CFSEdim target splenocytes were incubated with
LCMV-derived NP396-404 peptide, while CFSEbright control splenocytes were incubated
with ovalbumin-derived SIINFEKL peptide for 1h at 37°C. 5x103 target cells were mixed
with 5x103 control cells. GFP+ and GFP- CD8+ T cells from d8 LCMV-infected mice were
separated by cell sorting and percentages of GFP+ and GFP- NP396-specifc CD8+ T
cells were determined by flow cytometry after tetramer staining. Increasing doses of
GFP+ and GFP- NP396-specifc CD8+ T cells were added to wells containing target and
control cells. Unlabeled, wildtype CD45.2 CD57BL/6 splenocytes were used to
normalize cell concentrations in each well. After 6 or 24 hr incubation at 37°C, target cell
destruction was assessed by flow cytometry. % specific lysis was calculated as 100 * [1
– (% target cell remaining / % control cell remaining)].

2.3 Results
2.3.1 Expression of Eomesgfp is largely restricted to cytotoxic lineages and correlates
with Eomes protein expression.
Eomes expression has been reported in a variety of cell types during different
stages of lymphocyte differentiation. We first validated whether expression of Eomesgfp
faithfully matched Eomes expression by correlating GFP expression with previous
reports of Eomes mRNA or protein.
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In the hematopoietic system, Eomes is expressed predominantly in cytotoxic
lymphocytes (Pearce et al., 2003). We therefore determined whether Eomesgfp
expression followed a similar distribution within leukocyte lineages. In Eomesgfp/+ mice,
NK and CD8+ T cells contained the highest frequency of GFP+ cells, while GFP
expression in CD4+ T cells, B cells, and other lymphocyte lineages remained low or
undetectable (Fig 2.1A). The small population of GFP+ CD4+ T cells may represent a
recently described subset of memory TH2 cells (Endo et al., 2011). In other blood cells,
such as monocyte and granulocyte populations, GFP expression was undetectable (data
not shown).
As GFP expression was heterogeneous in NK and CD8+ T cells (Fig 2.1A), we
examined whether Eomesgfp activity matched previous reports of Eomes protein
expression in different CD8+ T cell subsets. We have recently identified an important role
for Eomes in the generation of central memory CD8+ T cells (Banerjee et al., 2010).
Consistent with Eomes protein expression (Banerjee et al., 2010), central memory
phenotype (CD44hiCD62Lhi) CD8+ T cells (Tcm) from unmanipulated mice exhibited a
high frequency of GFP expression, whereas naïve (CD44lo) and effector memory
phenotype (CD44hiCD62Llo) CD8+ T cells (Tem) had lower frequency of GFP expression
(Fig 2.1B). Notably, a minority of central memory phenotype CD8+ T cells remained
GFP-. We therefore hypothesized that Eomes might regulate a subset of central memory
phenotype CD8+ T cells.
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Figure 2.1. Expression of Eomesgfp is largely restricted to cytotoxic lineages and
correlates with Eomes protein expression.
Flow cytometry of GFP expression in indicated subpopulations of (A) mature
splenocytes and (B) splenic CD8+ T cells from unmanipulated Eomes+/+ (filled
histograms) and Eomesgfp/+(open histograms) mice. (C) GFP expression positively
correlates with a target of Eomes, CD122, in central memory CD8+ T cells. Flow
cytometry of CD122 versus GFP expression in effector and central memory phenotype
CD8+ T cells. Numbers denote frequency within the gated population.
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The beta chain for the IL-15 receptor (CD122), a direct target of Eomes
(Intlekofer et al., 2005), is important for homeostasis of memory CD8+ T cells by
supporting basal homeostatic proliferation (Becker et al., 2002; Goldrath et al., 2002;
Tan et al., 2002). We therefore examined whether Eomesgfp expression correlated with a
known Eomes transcriptional target in memory CD8+ T cells. Effector memory phenotype
CD8+ T cells expressed low levels of both GFP and CD122. In contrast, central memory
phenotype CD8+ T cells expressed high levels of CD122 and GFP, with a high frequency
of GFP and CD122 co-expression (Fig 2.1C). Thus, the Eomesgfp targeted allele
matches Eomes protein expression and trans-activation by Eomes.
2.3.2 GFP expression quantitatively parallels Eomes protein expression.
We next addressed whether activity of the Eomesgfp locus matched quantitative
changes in Eomes protein expression. Mice and humans with mutations in Fas or FasL
suffer from autoimmune and lymphoproliferative syndrome (ALPS). A major feature of
ALPS is lymphadenopathy and splenomegaly due to the accumulation of αβ TCRbearing CD4−CD8− (double-negative [DN]) T cells. These DN T cells express substantial
levels of Eomes and Eomes expression is critical for their accumulation (Kinjyo et al.,
2010). We chose to employ this model of Fas deficiency to examine whether activity of
the Eomesgfp locus would quantitatively match enhanced Eomes protein expression.
Examination of NK, CD4+, CD8+, and DN T cells from FasWT/WT Eomesgfp/+ mice revealed
that GFP+ cells in each population expressed similar amounts of GFP per cell as
measured by MFI of GFP+ cells (Fig 2.2A). In Faslpr/lpr Eomesgfp/+ mice, however, CD4+
and CD8+ T cells exhibited a 1.5 fold enhancement of GFP expression over NK cells,
while DN T cells demonstrated greater than 2-fold increase in GFP expression (Fig
2.2A). The fold enrichment of GFP expression paralleled increases in Eomes protein
23
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Figure 2.2. GFP expression quantitatively matches Eomes protein expression.
Flow cytometry of (A) GFP or (B) Eomes protein expression in indicated splenic
subpopulations from Eomes+/+ (filled histograms) and Eomesgfp/+(open histograms) mice
with indicated Fas genotype. Numbers denote GFP MFI and Eomes MFI of GFP+ and
Eomes+ cells, respectively. (C) GFP expression is specific for Eomes expression in
lymphocytes. Flow cytometry of intracellular staining for Eomes and GFP protein in NK
and central memory CD8+ T cells from Eomes+/+ and Eomesgfp/+ mice.
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expression (Fig 2.2B). Thus, the dynamic range of Eomes expression in DN T cells
during ALPS is primarily regulated at the transcriptional level. In addition, the activity of
the Eomesgfp locus can discriminate between quantitative changes in Eomes protein
levels.
To further confirm that Eomesgfp expression correlates with Eomes protein
expression in NK and CD8+ T cells, we directly compared Eomes and GFP protein
levels. GFP fluorescence is lost upon fixation and permeabilization for Eomes protein
staining due to direct quenching of fluorescence, loss of GFP protein from the cell, or a
combination thereof. As a result, we measured GFP expression by directly staining for
GFP protein using an anti-GFP antibody followed by an Alexa Flour 488 conjugated
secondary antibody. Intracellular staining revealed a positive correlation between Eomes
and GFP protein expression, as all GFP+ cells were Eomes+ (Fig 2.2C). Of note, a
fraction of both NK and CD8+ T cells expressed Eomes protein without immunologic
detection of GFP protein (Fig 2.2C). Consequently, Eomesgfp locus activity may be a
specific, but not entirely sensitive, reporter of Eomes protein expression in lymphocyte
populations.
2.3.3 Eomes expression does not identify the most cytotoxic effector CD8+ T cells.
Eomes has been reported to transcriptionally activate several genes associated
with cytotoxic capacity, such as those encoding perforin and granzyme B protein
(Pearce et al., 2003; Pipkin et al., 2010). Furthermore, in vitro culture conditions that
induce heightened expression of Eomes in CD8+ T cells are associated with more potent
cytotoxicity than those conditions resulting in lower Eomes (Pipkin et al., 2010).
However, direct analysis of whether Eomes expression leads to enhanced cytotoxic
potential is lacking. To this end, Eomesgfp/+ reporter mice were infected with lymphocytic
25

choriomeningitis virus (LCMV) Armstrong to assess whether Eomes expression
correlates with enhanced cytotoxicity in effector CD8+ T cells.
We first examined whether Eomesgfp expression enriched for terminal effector or
memory precursor cells. We have previously reported that Eomes protein is equally
distributed between these two subsets (Banerjee et al., 2010). Consistent with our
previous observations, virus-specific GFP+ and GFP- CD8+ T cells displayed equal
expression of terminal effector markers such as KLRG1 and memory markers such as
CD127 or CD27 (Fig 2.3A).
To determine whether Eomes expression conferred enhanced cytolytic potential,
we assessed whether Eomes expression was associated with enhanced degranulation
and increased expression of cytotoxic molecules. As peptide stimulation leads to TCR
downregulation and loss of tetramer staining, we utilized cells from P14 TCR transgenic
mice, where we could track virus-specific cells by congenic markers. Eomesgfp/+ P14
CD8+ T cells were isolated one week post-infection and stimulated with cognate peptide.
GFP+ and GFP- P14 CD8+ T cells displayed equal levels of degranulation as measured
by CD107a (LAMP-1) staining (Fig 2.3B). We next evaluated whether Eomes
expression led to enhanced transcription of cytotoxic molecules. Eomesgfp/+ P14 CD8+ T
cells from LCMV-infected mice were sorted based on GFP expression. Comparison of
GFP+ and GFP- effector CD8+ T cells revealed a modest reduction in the expression of
granzyme B and perforin mRNA in GFP+ cells compared to GFP- cells, although this
trend was not statistically significant (Fig 2.3C).
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Figure 2.3. Eomes expression does not correlate with enhanced cytotoxicity.
Endogenous or P14 Eomesgfp/+ CD8+ T cell responses were assessed after LCMV
infection. (A) GFP expression in CD8+ T cells is not biased towards terminal effector or
memory precursor cells. GFP+ and GFP- np396-specific CD8+ T cells were assessed for
KLRG1, CD127, and CD27 expression 8 days post-infection. (B) Eomes expression
does not correlate with enhanced degranulation. Eomesgfp/+ P14 CD8+ T cells were
stimulated with or without Dbgp33-41 peptide 7 days post-infection. Degranulation was
assessed by CD107a staining. (C) Eomes expression does not correlate with enhanced
transcription of cytotoxic molecules. Eomesgfp/+ P14 CD8+ T cells were sorted based on
GFP expression 7 days post-infection and assessed for Perforin and Granzyme B
mRNA expression. mRNA levels were normalized to HPRT and are reported relative to
naïve cells. (n.s.; Wilcoxon matched pairs test). (D) Cytolytic activity of GFP+ and GFPCD8+ T cells. Sorted GFP+ and GFP- CD8+ T cells were equalized for NP396-specific
CD8+ T cells and added to target cells pulsed with LCMV-derived peptide NP396-404. %
specific lysis was determined by the loss of target cells compared to control cells.
Graphs displays mean ± S.E.M.
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Last, we determined whether Eomes expression influenced the cytotoxic
potential of effector CD8+ T cells. Sorted GFP+ and GFP- CD8+ T cells displayed
equivalent cytotoxicity on a per cell basis in an in vitro killing assay (Fig 2.3D). Thus,
while Eomes may activate genes encoding cytotoxic molecules early after T cell
activation in vitro, Eomes expression does not correlate with enhanced cytotoxicity in
fully differentiated in vivo generated effector T cells. Consequently, robust killing may be
independent of Eomes expression at this stage of the CD8+ T cell response.
2.3.4 Progressive enrichment of Eomes expression in memory CD8+ T cells.
Compared to effector CD8+ T cells at the peak of cellular expansion, memory
CD8+ T cells have elevated Eomes expression (Banerjee et al., 2010; Intlekofer et al.,
2005). Whether this elevated expression is due to selection of Eomes+ memory CD8+ T
cells, gradual induction of Eomes expression in Eomes- memory CD8+ T cells, or a
combination of the two is unclear. To assess whether Eomes enrichment is due to
selection or induction, we first examined GFP expression longitudinally in virus-specific
Eomesgfp/+ CD8+ T cells after infection with LCMV.
As noted above, GFP expression was elicited in virus-specific CD8+ T cells at the
peak of expansion (d8). During the contraction phase, however, a consistent reduction in
GFP expression was observed (d8-d15) (Fig 2.4A). Nevertheless, as the memory
population matured (d15-d60), GFP expression was progressively enriched (Fig 2.4A),
consistent with elevated Eomes expression in late virus-specific memory (Banerjee et
al., 2010; Intlekofer et al., 2005).
As Eomes expression is important for central memory CD8+ T cells (Banerjee et
al., 2010), it is possible that expression of Eomes early after activation would lead to
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enhanced memory formation (Rao et al., 2010), however this hypothesis has not been
formally examined. To determine whether early Eomes expression correlates with the
formation of long-lived, Eomes+ CD8+ T cells, P14 Eomesgfp/+ CD8+ T cells were sorted
based on relative GFP expression 8 days post-infection and transferred into infectionmatched controls. While analysis of GFP expression revealed a modest downregulation
of Eomes in the first week after viral clearance, 80-90% of GFP+ cells retained Eomes
expression (Fig 2.4B, 2.5A). In contrast, GFP- cells largely remained GFP- (Fig 2.4B,
2.5A). Thus, the majority of Eomes expression in the memory population appears to
arise during the initial phase of the antiviral response.
We next tested whether early Eomes expression was associated with improved
memory differentiation. P14 Eomesgfp/+ CD8+ T cells that were separated by GFP
expression at day 8 post-infection gave rise to equal numbers of memory cells, with a
modest trend towards enhanced homing to the bone marrow (Fig 2.5B). The CD8+ T cell
population with early Eomes expression, however, did mature more rapidly to central
memory, as measured by the expression of CD62L (Fig 2.5C, D). Thus, while early
Eomes expression may not be associated with enhanced survival into the memory
phase, early induction of the Eomes locus correlates with more efficient central memory
formation.
2.3.5 Expression of the Eomes locus is reduced in the absence of Eomes protein.
We next evaluated whether CD8+ T cells stably transcribe the Eomes locus in the
absence of Eomes protein. To test this, we generated Eomesgfp/flox mice with or without
Cre recombinase under the control of the CD4 promoter (CD4-Cre).
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Figure 2.4. Progressive enrichment of Eomes expression in memory CD8+ T cells.
Endogenous or P14 Eomesgfp/+ CD8+ T cell responses were assessed after LCMV
infection. (A) Induction of Eomes expression is biphasic. Longitudinal GFP expression in
gp33-specific CD8+ T cells from the blood of Eomesgfp/+ mice at indicated days postinfection. (B) Early expression of Eomes is predominantly stable. Eomesgfp/+ P14 CD8+ T
cells were sorted based on GFP expression 8 days post-infection and transferred into
infection-matched controls. Plots display GFP expression of sorted populations in the
blood at indicated days post-infection. Numbers indicate frequencies within gated
populations. Graph displays mean ± S.E.M.
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Figure 2.5. Early expression of Eomes is associated with more efficient central
memory generation. Eomesgfp/+ P14 CD8+ T cells were sorted based on GFP
expression 8 days post-infection and transferred into infection-matched controls as in
Fig 2.4B. (A) Plots display GFP expression of sorted populations recovered from blood,
spleen and bone marrow 45 days post-transfer (53 days post-infection). (B) Total P14
Eomesgfp/+ CD8+ T cells recovered in (A). (C) CD62L expression of sorted populations
from (A). (D) Quantification of %CD62Lhi and CD62L MFI of CD62Lhi cells from (C).
Numbers indicate frequencies within gated populations. Graphs display mean ± S.E.M.
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Eomesgfp/flox mice contain a high frequency of CD8+ T cells with a phenotype of
long-lived, self-renewing central memory, e.g. expressing L-selectin (CD62L) and
components of the IL-15R (CD122) and IL-7R (CD127) (Fig 2.5; left column).
Consistent with a role for Eomes in the support of central memory CD8+ T cell
differentiation (Banerjee et al., 2010), a majority of these central memory phenotype
CD8+ T cells express GFP (Fig 2.5; left column). Deletion of Eomes led to reduced
expression of all three markers of long-lived memory CD8+ T cells and to a reduced
frequency of GFP+ cells (Fig 2.5; right column). In particular, less than of quarter of
CD62Lhi, CD122hi, or CD127hi CD8+ T cells maintained GFP expression in the absence
of Eomes protein (Fig 2.5; right column). Quantification of GFP+ and GFP- central
memory phenotype CD8+ T cells suggested that the lower GFP expression was due to
specific loss of the Eomes+ subset rather than reduced Eomes locus activity (Fig 2.5B).
In the absence of Eomes, central memory CD8+ T cells fail to maintain a longlived, stable population, presumably due to decreased homeostatic proliferation as a
result of reduced bone marrow homing (Banerjee et al., 2010). To determine whether the
specific loss of GFP+ central memory phenotype CD8+ T cells resulted from poor
homeostatic proliferation, we sorted GFP+ CD44hi CD62Lhi CD8+ T cells from Eomesgfp/flox
mice with or without CD4-Cre, labeled the cells with a cell proliferation dye (Violet Cell
TrackerTM), and transferred them into congenically disparate hosts. Analysis of cell
division after one month in vivo demonstrated reduced homeostatic proliferation in
Eomes-deficient CD8+ T cells (Fig 2.6A). Thus, central memory CD8+ T cells that
activate Eomes transcription also become dependent upon Eomes protein for
persistence.
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Figure 2.6. Central memory cells with an active Eomes locus are reduced in the
absence of Eomes protein. (A) Flow cytometry of CD62L, CD122, and CD127 versus
GFP expression in splenic CD44hi CD8+ T cells from mice with indicated genotype.
Numbers denote frequency of cells in each quadrant. Eomes protein expression is also
shown for the Cre-negative (open) and Cre-positive (filled) populations. (B) Total GFPand GFP+ central memory (CD44hi CD62Lhi) cells in the presence (Cre-negative; open)
or absence (Cre-positive; filled) of Eomes protein. (C) Sorted GFP+ central memory
(CD44hi CD62Lhi) cells were labeled with a cell division dye (CellTrackerTM Violet) and
transferred into CD45.1 congenic recipients. Plots display GFP expression versus
CellTrackerTM Violet after 4 weeks in vivo.
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2.3.6 Eomesgfp allows for detection of putative intermediates of NK cell development.
TRAIL+DX5- NK cells appear to represent developmental intermediates of NK cell
maturation. Adoptive transfer of TRAIL+DX5- NK cells has been shown to generate
TRAIL-DX5+ NK cells in recipient mice (Gordon et al., 2012; Takeda et al., 2005).
Deletion of Eomes, however, prevents NK cells from progressing past the TRAIL+DX5precursor stage (Gordon et al., 2012). Whether TRAIL+DX5- NK cells activate Eomes
expression prior to the maturation into TRAIL-DX5+ NK cells is not known. To investigate
whether Eomes transcriptional activation occurs prior to maturation, we examined
Eomesgfp activity in NK cells in the presence or absence of Eomes protein.
We first determined that GFP expression correlated with markers of NK
maturation. In Eomesgfp/+ mice, GFP expression was restricted to TRAIL-DX5+ NK cells
(Fig 2.7A), consistent with Eomes protein expression (Gordon et al., 2012). In the
absence of Cre, Eomesgfp/flox NK cells are able to express one functional copy of Eomes
and appropriately generate a high frequency population of TRAIL- DX5+ NK cells that
express both GFP and Eomes protein (Fig 2.7B,C; left column). As expected, NK cells
from Eomesgfp/flox mice harboring Cre had a severe reduction in the frequency of mature
TRAIL-DX5+ NK cells and a selective enrichment for TRAIL+DX5- precursors (Fig
2.7B,C; right column). Nevertheless, Eomes deficient NK cells contained a small
population of cells that expressed high levels of both GFP and TRAIL (Fig 2.7B; top
row). The dual expression of GFP and TRAIL suggests that a population of TRAIL+DX5precursors receive differentiation signals and activate Eomes transcription in the initial
stages of the development of mature NK cells.
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Figure 2.7. Eomesgfp allows for detection of putative intermediates of NK cell
development. (A) GFP is predominantly expressed in mature TRAIL- DX5+ NK cells.
Flow cytometry of TRAIL, DX5 and GFP expression in liver NK cells. (B) Flow cytometry
of TRAIL or DX5 versus GFP or Eomes protein expression in liver NK cells from mice
with indicated genotype. Numbers denote frequency of cells in each quadrant.
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2.4 Discussion
In this study, we described the GFP expression of an Eomesgfp targeted allele in
the adult leukocyte compartment and matched Eomes and GFP expression in mature
lymphocytes. While Eomes expression did not segregate with differential cytotoxicity in
effector CD8+ T cells, early Eomes expression did lead to more efficient central memory
formation. In addition, central memory CD8+ T cells that activate the Eomes locus may
become dependent on Eomes protein for persistence and homeostatic proliferation.
Lastly, GFP expression in Eomes-deficient NK cells enabled the identification of a
putative intermediate of NK cell development.
Retroviral-based overexpression of Eomes appears to initiate a cytotoxic
transcriptional program, activating effector genes such as IFN-γ, granzyme B, and
perforin (Cruz-Guilloty et al., 2009; Pearce et al., 2003; Pipkin et al., 2010). Furthermore,
in cultures with high IL-2 concentration, higher expression of Eomes correlates with
CD8+ T cell killing capacity (Hinrichs et al., 2008; Pipkin et al., 2010). However, whether
the enhanced killing capacity is a direct result of increased Eomes expression was not
addressed. With the availability of an Eomesgfp reporter, we were able to separate cells
with high Eomes expression from cells with negative or low Eomes expression within the
same population. We found that higher Eomes expression did not correlate with higher
expression of the cytotoxic molecules granzyme B and perforin nor with enhanced
cytotoxicity in fully differentiated effector CD8+ T cells. One possible resolution to this
paradox is that Eomes may play a more important role earlier, in acquiring cytotoxic
potential, rather than in exerting cytotoxic function. Alternatively, the equivalent cytotoxic
molecule expression and cytotoxicity of GFP+ and GFP- subsets may be due to the
redundancy of other transcription factors at this stage of the CD8+ T cell response. In
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particular, the T-box factor T-bet plays a redundant role with Eomes in the induction of
the cytotoxic program in effector CD8+ T cells (Intlekofer et al., 2008). Indeed, previous
work indicates that deletion of Eomes did not appreciably affect the killing capacity of
effector CD8+ T cells (Intlekofer et al., 2008).
Other transcription factors may also contribute to cytotoxic gene expression in
the absence of Eomes. Notch (Cho et al., 2009) and Runx3 (Cruz-Guilloty et al., 2009)
can both bind to the granzyme B and perforin loci and activate their transcription. In
addition, differential signaling through Akt can modulate perforin expression without
altering T-bet or Eomes expression (Macintyre et al., 2011), suggesting T-box factor
independent pathways for cytotoxic gene regulation. As a result, multiple transcription
factors may compensate for lack of Eomes in activating cytotoxic genes in effector CD8+
T cells.
We have recently reported a role for Eomes in the generation of central memory
CD8+ T cells in response to viral infection (Banerjee et al., 2010). As the homologous Tbox factor T-bet drives the terminal differentiation of effector CD8+ T cells, one might
hypothesize that Eomes would conversely drive formation of memory precursors. Eomes
expression, however, did not correlate with markers of memory precursor cells, nor did
deletion of Eomes impair the generation of memory precursors (Banerjee et al., 2010).
Nevertheless, early Eomes expression was associated with more rapid accumulation of
central memory CD8+ T cells. Therefore, Eomes likely supports memory differentiation
after the stage of memory cell fate commitment. When Eomes begins to contribute to the
program of memory differentiation, however, remains to be determined.
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In CD8+ T cells expressing markers of long-lived, self-renewing central memory,
Eomes protein expression was important for maintaining cells with stable expression of
the Eomes locus. This failed persistence of CD8+ T cells that would normally express
Eomes transcripts in the absence of Eomes protein appeared to be due to the impaired
homeostatic proliferation. Thus, Eomes- central memory CD8+ T cells may contain a
distinct program for survival compared to Eomes+ central memory cells.
We and others have reported the development of mature TRAIL-DX5+ NK cells
from TRAIL+DX5- NK cells. However, the signals that initiate full maturation of
TRAIL+DX5- precursors are unknown. Furthermore, the transcriptional events initiating
the developmental program of NK maturation are similarly obscure. By examining
Eomes-deficient NK cells carrying an Eomesgfp reporter allele, we were able to identify a
small population of TRAIL+DX5- precursors that had activated Eomes transcription and
potentially initiated subsequent steps in NK cell maturation. However, in the absence of
Eomes protein, these GFP+TRAIL+ cells did not accumulate. Future studies will be
needed to determine whether these cells fail to persist in the absence of Eomes protein
as they progress through NK cell development or whether they return to the TRAIL+DX5precursor program and repress Eomes expression. Further exploration of GFP+
TRAIL+DX5- precursors offers a novel opportunity to define the factors influencing NK
cell maturation.
Correlation of GFP protein with Eomes protein in Eomesgfp/+ mice revealed a
population of NK and CD8+ T cells that express Eomes without GFP. The specificity, but
incomplete sensitivity, of the inserted EGFP in the Eomes locus raises new potential
insights into the regulation of Eomes expression in lymphocytes. One possibility is that
the level of GFP protein needed for antibody or fluorescent detection is greater than the
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level of Eomes protein required for equivalent detection. A second possibility, however,
is that Eomes protein exhibits a longer half-life than that of EGFP. Thus, low
transcriptional activity of the Eomes locus may lead to low levels of Eomes protein but
undetectable levels of EGFP. This notion is consistent with the observation that small
differences in Eomes mRNA (Intlekofer et al., 2005) can lead to large differences in
Eomes protein (Banerjee et al., 2010). Investigations into the control of Eomes protein
stability could allow for the potential to manipulate Eomes concentration in both healthy
(Banerjee et al., 2010; Gordon et al., 2011; Gordon et al., 2012; Intlekofer et al., 2008;
Intlekofer et al., 2005) and diseased states (Kinjyo et al., 2010).
The ability to separate lymphocytes based on graded transcription factor
expression is restricted to either the identification of correlative surface markers (Joshi et
al., 2007) or the generation of reporter mice. This need is especially compelling in the
case of transcription factors that exhibit a large dynamic range of expression within a
single population. Thus, the generation of an Eomesgfp/+ reporter that exhibits robust
fidelity to Eomes protein expression in cytotoxic lymphocytes should prove to be a
beneficial tool in elucidating how heterogeneous Eomes expression results in differential
fate or function.
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CHAPTER 3: A critical role for balancing progenitor and terminal
subsets of exhausted CD8+ T cells during chronic viral infection
3.1 Introduction:
Chronic viral infections, such as HIV, HBV, and HCV, contribute to substantial
morbidity and mortality worldwide (Virgin et al., 2009). Defects in adaptive immune
responses, such as CD8+ T cell exhaustion, limit complete viral control (Wherry, 2011).
Exhausted CD8+ T cells do, however, provide some level of containment of these
viruses. For example, depletion studies in SIV infected macaques or HCV infected
chimpanzees demonstrate the central importance of T cells in these settings (Grakoui et
al., 2003; Jin et al., 1999; Schmitz et al., 1999; Shoukry et al., 2003). Moreover,
molecular escape from CD8+ (and CD4+) T cell responses during chronic viral infection
demonstrates the important pressure that even exhausted CD8+ T cell place on chronic
viral infections. However, these antiviral CD8+ T cells are under tremendous pressure
and often receive strong, ongoing antigenic stimulation throughout the course of chronic
infection.
Previous examination of T cells during HIV infection revealed a dramatic increase
in the level of CD8+ T cell proliferation and turnover during the chronic phase of infection
(Hazenberg et al., 2000; Hellerstein et al., 1999; McCune et al., 2000; Sachsenberg et
al., 1998). One contributing factor to this high rate of CD8+ T cell turnover may be the
virus-specific CD8+ T cell response. Consistent with this hypothesis, in a murine model
of chronic viral infection, virus-specific CD8+ T cells displayed extensive proliferation in
vivo (Shin et al., 2007). The high rate of replication and cell turnover, however, may also
lead to detrimental effects on the CD8+ T cell response. For example, HIV-infected
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individuals with higher rates of T cell proliferation and corresponding immune activation
have an accelerated rate of disease progression (Giorgi et al., 1999; Hazenberg et al.,
2000). Thus, how virus-specific CD8+ T cells might adapt during chronic infections to
continuously repopulate the anti-viral CD8+ T cell pool over a prolonged period are
unknown.
After initial infection and effector expansion, CD8+ T cells undergo contraction
both when the infection is rapidly cleared and when the pathogen persists. Following
acute infections, memory CD8+ T cell populations form. These memory CD8+ T cells
return to quiescence but acquire the ability to self-renew in an antigen-independent
manner, utilizing IL-7 and IL-15 for their maintenance (Becker et al., 2002; Goldrath et
al., 2002; Lau et al., 1994; Murali-Krishna et al., 1999; Tan et al., 2002; Wiehagen et al.,
2010). During chronic infection, however, antigen-independent memory CD8+ T cells
often do not develop. Instead, a stable population of CD8+ T cells persists via a distinct,
antigen-dependent type of maintenance that remains poorly understood.
Over the lifespan of an organism, several tissues experience extensive cell
turnover and repeatedly repopulate a terminally differentiated population. These tissues,
such as the epithelium of the skin and gut, adapt to these demands by having a
collection of long-lived precursor cells that give rise to a short-lived and terminallydifferentiated cell population. Often, this process is coupled to extensive division,
allowing for a small population of progenitors to maintain the much larger population of
cells that execute tissue-specific functions.
In the case of chronic infection, where virus-specific CD8+ T cells experience the
stress of constant antigenic stimulation, a similar phenomenon might occur. In this case,
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a small population of cells would be dedicated to longevity of the CD8+ T cell response
by preserving the unique TCR sequence that confers antigen specificity. This small
population, however, would act as precursors and would repeatedly give rise to a much
larger, more differentiated, anti-viral CD8+ T cell population. Whether this process occurs
in virus-specific CD8+ T cells during a chronic infection is unclear. Furthermore, what
transcription factors would govern this process is not known.
Eomesodermin (Eomes) and T-bet are homologous T-box transcription factors
(Pearce et al., 2003; Russ et al., 2000; Szabo et al., 2000) that are involved in a variety
of developmental processes. Both transcription factors support the anti-viral CD8+ T cell
response, in part through their activation of a number of genes encoding effector
molecules, such as IFN-g, perforin, and gramzyme B (Intlekofer et al., 2008; Lewis et al.,
2007; Pearce et al., 2003; Szabo et al., 2000; Townsend et al., 2004). Consequently,
expression of these factors has been associated heretofore with effective and functional
CD8+ T cell responses.
In some cases, however, two related T-box factors may promote alternative cell
states along similar differentiation processes. For example, in acutely-resolved
infections, T-bet directs CD8+ T cells to adopt a terminally-differentiated cell fate during
the acute effector phase of the response (Intlekofer et al., 2007; Joshi et al., 2007), while
Eomes supports the persistence of long-lived, self-renewing central memory CD8+ T
cells long after the pathogen is cleared (Banerjee et al., 2010). Whether Eomes and Tbet govern alternative cell states in CD8+ T cells during a chronic viral infection,
however, is unknown.
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Here we report that, unlike T-bet which is down-regulated during dysfunctional
CD8+ T cell responses to a chronic viral infection (Kao et al., 2011), Eomes is strongly
upregulated in virus-specific CD8+ T cells. In addition, Eomes expression correlates with
features of severe exhaustion. Nevertheless, Eomes expression is essential for
maintaining the maximal CD8+ T cell response to limit viral replication. Eomes and T-bet
support the persistence of two distinct subsets during the CD8+ T cell response to a
chronic viral infection. T-bethi Eomeslo CD8+ T cells exhibit low levels of proliferation and
cell turnover in vivo; however these cells acts as progenitor cells that give rise to the Tbetlo Eomeshi population, a process that is coupled to extensive cell division. This
amplified population then has a more limited ability to give rise to more progeny. Thus,
Eomes and T-bet govern the balance between terminal differentiation and population
renewal in CD8+ T cells during chronic viral infection.

3.2 Methods:
3.2.1 Human Subjects:
All human subjects were recruited at the Massachusetts General Hospital
Gastrointestinal Unit and the Department of Surgery in accordance with the IRB
approved study: “Cell mediated immunity in Hepatitis C virus infection”; Protocol # 1999P-004983/54; MGH Legacy #: 90-7246. Liver specimens were obtained from
explantation or resection of 8 patients with at least 5 years of chronic HCV infection,
defined by positive anti-HCV antibody and detectable viral load. Three patients with
treatment induced sustained virological response (SVR, undetectable viral load 6
months after end of treatment) were analyzed. SVR of all 3 patients was achieved at
least 3 years prior to liver sampling. Intrahepatic lymphocytes (IHL) were extracted by
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mechanical disruption of liver tissue. The cell suspension was then washed twice in
RPMI 1640 culture medium supplemented with 10% FBS, followed by centrifugation at
300 rpm each time to remove cell debris and hepatocytes. The final washing step was
followed by centrifugation at 1500 rpm to obtain a pellet of IHL.
3.2.2 Mice and Infections:
All animals were housed at the University of Pennsylvania (Philadelphia, PA).
Experiments were performed in accordance with protocols approved by the University of
Pennsylvania Institutional Animal Care and Use Committee. Eomesflox/flox, Eomesgfp/+,
and Tbx21-/- (T-bet KO) mice have been described previously (Arnold et al., 2009;
Finotto et al., 2002; Intlekofer et al., 2008). To examine CD8+ T cell differentiation in the
absence of Eomes, Eomesflox/flox mice were crossed to CD4-Cre mice (Eomes cKO)
(Intlekofer et al., 2008). CD4-Cre+ Eomes+/+ or littermate CD4-Cre- Eomesf/f mice were
used as WT controls. Mice were infected with either 2 x 105 PFU of lymphocytic
choriomenigitis virus (LCMV) Armstrong strain by i.p. injection to generate an acutely
resolved infection or 4 x 106 PFU of LCMV clone 13 strain by i.v. injection to generate a
chronic infection. The V35A variant of clone 13 has been previously described (Blattman
et al., 2009; Shin et al., 2007).
3.2.3 Flow cytometry and real-time PCR:
Surface staining was performed as described previously (Gordon et al., 2011;
Intlekofer et al., 2008). Intracellular staining was performed using the Foxp3 /
Transcription Factor Staining Buffer Set per manufacturer’s instructions (eBioscience;
San Diego, CA). Antibodies used for flow cytometry were purchased from BD
Biosciences (CD4, CD8, CD19, CD44, 2B4, Ki-67; San Jose, CA), Biolegend (PD-1,
Tim3, TNF-α, IFN-γ, T-bet; San Diego, CA), R&D Systems (MIP-1α; Minneapolis, MN),
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or eBioscience (CD8, Lag3, CD160, 2B4, CD45.1, CD45.2, CD107a, Eomes). MHC
class I peptide tetramers were made and used as described previously (Wherry et al.,
2004; Wherry et al., 2003a). Data were collected on a BD LSRII (BD Biosciences) and
analyzed with FlowJo software (Tree Star, Ashland, OR). Cell sorting was performed
using a BD Aria II (BD Biosciences). qRT-PCR was carried out as previously described
(Gordon et al., 2012; Intlekofer et al., 2008). Gene expression was normalized to
GAPDH. Target gene probes were purchased from Applied Biosystems (Foster City,
CA).
3.2.4 Bone Marrow Chimeras
Bone marrow (BM) from WT (CD45.1+), T-bet KO (CD45.2+), and Eomes cKO
(CD45.2+) donors was harvested. 5-10 x 106 donor cells were transferred i.v. into
sublethally irradiated (450 rads) Rag2-/- recipients. 8 weeks after BM transfer, chimeras
were infected with LCMV clone 13.
3.2.5 BrdU Treatment and Detection
Animals were treated with 2mg of BrdU (Sigma-Aldrich; St. Louis, MO) i.p. daily
for 7 days prior to tissue harvest and analysis. BrdU incorporation was assessed by the
BrdU Flow Kit per manufacturer’s instructions (BD Biosciences).
3.2.6 CFSE labeling, temporal deletion and adoptive transfers:
At indicated days p.i., spleens were harvested from indicated CD45.2+ donor
mice. CD8+ T cells were purified from splenocytes using magnetic beads according to
manufacturer’s protocol (CD8+ negative selection; MACS beads; Miltenyi Biotec, Auburn,
CA). Purified CD8+ T cells were labeled with CFSE as described previously (Wherry et
al., 2004; Wherry et al., 2003a), and transferred i.v. into CD45.1+ infection-matched
46

controls. Temporal Eomes deletion with Tat-Cre was performed as described (Gordon et
al., 2012).
3.2.7 Statistical Analysis:
Student’s t test (Paired and Unpaired), Mann-Whitney test, and 2-way ANOVA
were performed using Prism software (Graphpad, La Jolla, CA).

3.3 Results:
3.3.1 Eomes expression is enhanced during chronic viral infection.
During chronic viral infections in humans and mice, T-bet expression is reduced
in virus-specific CD8+ T cells and this reduction correlates with T cell dysfunction
(Hersperger et al., 2011; Kao et al., 2011; Ribeiro-Dos-Santos et al., 2012). In contrast,
microarray analysis of CD8+ T cells has suggested that Eomes mRNA is elevated during
chronic infection (Wherry et al., 2007). We first validated these findings by RT-PCR in
sorted virus-specific CD8+ T cells from an acutely resolved infection with lymphocytic
choriomeningitis virus (LCMV) Armstrong (Arm) at day 8 (effector) and day 30 postinfection (memory) or from a chronic infection with LCMV clone-13 (cl-13) at day 30
post-infection (exhausted). Eomes expression was compared to naïve (CD44lo) CD8+ T
cells from uninfected mice. Consistent with microarray analysis, Eomes expression was
strongly upregulated during chronic infection (Fig 3.1A). We next determined whether
the elevated levels of Eomes was due to an increase in the frequency of cells expressing
Eomes or an increase in Eomes expression per cell. Infection of an Eomes GFP reporter
mouse (Eomesgfp/+) (Arnold et al., 2009) with LCMV Arm generated a modest frequency
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Figure 3.1. Eomes expression is enhanced during chronic viral infection. (A) Naïve
or gp276-specific CD8+ T cells from effector (Arm d8), memory (Arm d30), or exhausted
(cl-13 d30) time-points were sorted and analyzed for Eomes mRNA expression
normalized to GAPDH. (B) Longitudinal histograms of GFP expression in gp33-specific
CD8+ T cells from the blood of WT (shaded) or Eomesgfp/+ (open) mice at indicated days
post Arm or cl-13 infection. (C) Eomes protein expression in gp33-specific CD8+ T cells
from the spleens of WT mice 8, 15, or 30 days post-infection with Arm or cl-13. (B-C)
Numbers indicate frequencies of gated populations. (D) MFI of Eomes expression from
cells in (C).
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of GFP+ virus-specific CD8+ T cells (Fig 3.1B). In contrast, infection of Eomesgfp/+ mice
with LCMV cl-13 resulted in a robust frequency of GFP+ virus-specific CD8+ T cells (Fig
3.1B). Thus, the enhanced Eomes expression results – at least in part – from an
increase in the frequency of cells expressing Eomes mRNA.
We next validated that the enhanced Eomes mRNA expression resulted in
increased Eomes protein. Isolation of virus-specific CD8+ T cells from LCMV Arm or cl13 infected mice revealed high levels of Eomes protein expression at the peak of the
CD8+ T cell response (day 8 post-infection). Clearance of viral antigen during acute
infection led to an initial drop in Eomes expression at day 15 that subsequently
increased as the population began to mature into central memory (day 30). In contrast,
high levels of Eomes protein expression persisted during chronic viral infection (Fig
3.1C,D). Thus, Eomes expression is highly upregulated in virus-specific CD8+ T cells
during chronic viral infection.
3.3.2 Eomes expression correlates with features of CD8+ T cell exhaustion.
As CD8+ T cells during chronic viral infections exhibit heterogeneity in surface
phenotype, transcriptional profile, and function, we examined how Eomes expression
correlated with known features of CD8+ T cell exhaustion. We first investigated whether
Eomes expression was correlated with the expression of inhibitory receptors, which have
been demonstrated to impair optimal CD8+ T cell function during chronic viral infection
(Barber et al., 2006; Blackburn et al., 2010; Blackburn et al., 2009; Wherry, 2011).
Examination of virus-specific CD8+ T cells 30 days post-infection with LCMV cl-13
revealed a positive correlation between the expression of Eomes and several inhibitory
receptors (PD-1, Lag3, CD160, & Tim3) (Fig 3.2A).
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As Eomes appeared to correlate with markers of dysfunction (Blackburn et al.,
2009), we next determined how Eomes expression related to other transcription factors
that regulate CD8+ T cell responses during chronic viral infection. In particular, based on
the positive correlation between Eomes and inhibitory receptor expression, we predicted
a negative correlation between T-bet and Eomes (Kao et al., 2011) and a positive
correlation between Eomes and Blimp1 (Shin et al., 2009).
After an acute infection with LCMV Arm, Eomes did not strongly correlate –
positively or negatively – with the expression of T-bet (Fig 3.2B; top row). In contrast,
virus-specific CD8+ T cells from chronically infected mice developed a prominent inverse
correlation in the expression of T-bet and Eomes (Fig 3.2B; bottom row). In order to
evaluate Blimp1 and Eomes co-expression, we crossed Blimp1 YFP reporter mice
(Rutishauser et al., 2009; Shin et al., 2009) to Eomesgfp/+ mice. Dual reporter mice
revealed a modest frequency of YFP and GFP co-expression at the peak of the CD8+ T
cell response 8 days post-infection with LCMV Arm. This co-expression gradually
declined as the cell-population matured towards central memory (Fig 3.2C; top row).
Similar to acute infection, CD8+ T cells displayed a low frequency of YFP and GFP coexpression 8 days after LCMV cl-13 infection. However, chronic viral infection lead to a
substantial frequency of co-expression of YFP and GFP that persisted for at least two
months post-infection (Fig 3.2C; bottom row). Thus during chronic viral infection,
Eomes expression correlates with CD8+ T cells that exhibit phenotypic and
transcriptional characteristics of CD8+ T cell exhaustion.

50

!"#$%&'()*
+

A

A1

11

*(

*

*C

1(

43

C

B1

D

B(

15

4C

C

*A

9"-(

A

4

*,B

C3

@=1A5

15

>?#(

<=01

EF/&&G

67-&8

@

EF/&&G
214

23
3A

(3

A*

(*

A3

5

5

5

5

5

5

11

3D

C

D1

1B

3B

5

5

5

*

5

*

+%90:&;

,/772
214

23

2(5

1B

./01(

K!<'I,/"-F1J

,

2A5

11

3

A

4

(B

*1

H!<'I67-&8J

67-&8

Figure 3.2. Eomes expression correlates with phenotypic and transcriptional
features of CD8+ T cell exhaustion. (A) Eomes positively correlates with inhibitory
receptor expression. Plots display indicated inhibitory receptor expression versus Eomes
expression in gp33-specific CD8+ T cells 30 days post-infection. (B) T-bet and Eomes
inversely correlate in virus-specific CD8+ T cells during chronic infection. T-bet versus
Eomes expression in gp33-specifc CD8+ T cells 8, 15, or 30 days post-infection with Arm
or cl-13. Gates are based on naïve cells from uninfected mice. (C) Blimp1 and Eomes
co-expression is enriched during chronic infection. Longitudinal frequency of GFP+YFP+
gp33-specific CD8+ T cells in the blood of Blimp1-YFP/Eomesgfp/+ dual reporter mice
after Arm or cl-13 infection. Gates are based on WT and single reporter mice. Numbers
denote frequency of gated population.
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Figure 3.3. Eomes expression correlates with functional features of CD8+ T cell
exhaustion. (A) Eomes expression correlates with increased granzyme B expression.
Histograms of granzyme B expression in naïve (gray) or Eomes+ and Eomes- gp276specifc CD8+ T cells (open) 22 days post-infection. (B) Eomes expression correlates with
reduced degranulation. Histograms of CD107a staining of naïve (gray) or Eomes+ and
Eomes- MIP-1α+ CD8+ T cells (open) after stimulation with gp276-286 peptide on day 23
post-infection. (C) Eomes expression correlates with reduced co-expression of IFN-γ and
TNF-α. 22 days post-infection, CD8+ T cells were stimulated with gp33-41, gp276-286,
or a LCMV peptide pool and expression of IFN-γ and TNF-α was assessed for Eomes+
and Eomes- CD8+ T cells. Numbers denote frequency of gated population.
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We therefore examined how Eomes expression was associated with functional
changes associated with CD8+ T cell exhaustion. We have previously reported an
inverse correlation between inhibitory receptor expression and CD8+ T cell function
during chronic infection (Blackburn et al., 2010; Blackburn et al., 2009). The impaired
cytotoxicity is associated with reduced degranulation as measured by CD107a staining,
yet paradoxically increased staining for granzyme B (Blackburn et al., 2010). Consistent
with the positive correlation between Eomes and PD-1, granzyme B expression was
enhanced in Eomes-expressing CD8+ T cells (Fig 3.3A), whereas CD107a staining was
reduced (Fig 3.3B).
We have also reported that the expression of multiple inhibitory receptors
inversely correlates with cytokine expression, in particular co-expression of IFN-γ and
TNF-α (Blackburn et al., 2009). Therefore, we investigated whether Eomes expression
correlated with differential cytokine expression. Examination of Eomes+ and EomesCD8+ T cells that express MIP-1α or stain for CD107a after peptide stimulation revealed
equivalent frequencies of IFN-γ expression. In contrast, the ability to co-express IFN-γ
with TNF-α was reduced in Eomes+ CD8+ T cells compared to Eomes- CD8+ T cells (Fig
3.3C). Thus, Eomes expression is elevated in virus-specific CD8+ T cells that
phenotypically, transcriptionally, and functionally display features of terminal exhaustion.
3.3.3 Deletion of Eomes leads to reduced features of CD8+ T cell exhaustion.
While WT CD8+ T cells had bimodal expression of T-bet and Eomes, genetic
deletion of T-bet resulted in an increase in Eomes and PD-1 expression (Fig 3.4A),
consistent with enhanced exhaustion (Kao et al., 2011). In contrast, Eomes-deficient
CD8+ T cells had reduced PD-1 and Blimp1, as well as increased T-bet and functionality
(Fig 3.4B,C).
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Figure 3.4. Eomes deficient CD8+ T cells appear less exhausted. (A) T-bet, Eomes,
and PD-1 expression of Dbgp33-specific CD8+ T cells from WT, T-bet KO, and Eomes
cKO mice on d22 p.i. Numbers denote frequency of gated population. (B) Blimp1 relative
mRNA in Dbgp276-specific CD8+ T cells from WT and Eomes cKO mice on d15 p.i.
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IFN-γ and TNF-α expression after peptide pool stimulation as in Fig 3.3 on d22 p.i.
(**p<0.01; Unpaired t test).
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Figure 3.5. Eomes acts cell-intrinsically to maintain the more exhausted CD8+ T
cell population. Rag KO hosts were sublethally irradiated and reconstituted with a 1:1
mixture of WT and Eomes cKO bone marrow, followed by infection with LCMV clone 13.
(A) T-bet and PD-1 expression in Dbgp276-specific CD8+ T cells d60 p.i. Numbers
denote frequency of gated population. (B) MFI of T-bet and PD-1 expression from cells
in (A). (*p<0.05, **p<0.01; Paired t test)
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These features of reduced exhaustion in Eomes-deficient CD8+ T cells were
determined to be cell-intrinsic through the use of mixed bone-marrow chimeras (Fig 3.5).
Thus, T-bet and Eomes support separate subpopulations of virus-specific CD8+ T cells
during chronic viral infection.
3.3.4 T-bet and Eomes regulate distinct proliferative properties.
Previous studies in mice and humans suggest that proliferating and non-proliferating
subpopulations of exhausted CD8+ T cells might exist during chronic infections
(Hellerstein et al., 2003; Shin et al., 2007), but the regulation of this process is poorly
understood. We hypothesized that T-bethi and Eomeshi CD8+ T cells might have different
in vivo proliferative dynamics. While T-bethi CD8+ T cells had low Ki-67 expression and
BrdU incorporation, Eomeshi CD8+ T cells expressed Ki-67 and incorporated BrdU at
high frequencies in multiple anatomical sites, including the liver (Fig 3.6A-C). Using
CFSE labeling to trace division history and associated changes in differentiation in vivo,
we observed robust proliferation in Eomeshi CD8+ T cells, while less CFSE dilution was
found in the T-bethi population (Fig 3.6D). The modest proliferation of T-bethi cells was
unlikely the result of limited access to antigen, since essentially all virus-specific memory
CD8+ T cells divided extensively when transferred into chronically infected mice (Fig
3.7). In addition, T-bet and Eomes governed these distinct proliferative behaviors since
deletion of T-bet increased CD8+ T cell Ki-67 expression and BrdU incorporation, while
loss of Eomes diminished cell proliferation (Fig 3.8, 3.9). Thus, T-bet and Eomes
regulate distinct CD8+ T cell pools with differential division during chronic infection.
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Figure 3.6. T-bet and Eomes subsets exhibit differential proliferation. (A) Ki-67
expression is increased in T-betlo Eomeshi virus-specific CD8+ T cells. Flow cytometry of
T-bet, Eomes, and PD-1 expression versus Ki-67 expression in gp33-specific CD8+ T
cells 22 days post-infection. (B) BrdU incorporation is increased in T-betlo Eomeshi virusspecific CD8+ T cells. Infected WT mice were injected with 2mg of BrdU daily from day
15 to day 21 post-infection. Flow cytometry of T-bet, Eomes, and PD-1 expression
versus BrdU incorporation in gp33-specific CD8+ T cells 22 days post-infection. (C) BrdU
incorporation occurs predominantly in the T-betlo Eomeshi subset of virus-specific CD8+ T
cells in multiple tissues. Infected mice were treated with BrdU as in (B). Plots display
Eomes expression versus BrdU incorporation in gp276-specific CD8+ T cells from
indicated organs. (D) Extensive proliferation is associated with Eomes expression. CD8+
T cells from CD45.2 infected mice were isolated 15 days post-infection, CFSE-labeled,
and transferred into infection-matched CD45.1 hosts. One week post-transfer, virusspecific CD8+ T cells were analyzed for CFSE dilution. Plots show T-bet, Eomes, and
PD-1 expression versus CFSE dilution in gp276-specific donor CD8+ T cells. Numbers
indicate frequencies of gated populations.
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Figure 3.7. Lack of division in exhausted CD8+ T cells is not due to lack of
proliferative (antigenic) stimuli. (A) CD8+ T cells from CD45.2 LCMV Armstrongimmune (d30+) or clone 13 chronically infected (d30) mice were isolated, CFSE-labeled,
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T cells.
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Figure 3.8. Deletion of either T-bet or Eomes leads to opposite effects on
proliferation. Ki-67 expression in gp33-specific CD8+ T cells from WT, T-bet KO, and
Eomes cKO mice at indicated days post-infection.
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Figure 3.9. T-bet deficient CD8+ T cells exhibit enhanced proliferation, whereas
Eomes deficient CD8+ T cells display reduced proliferation. BrdU incorporation in
gp276-specific CD8+ T cells from WT, T-bet KO, and Eomes cKO mice. Mice were
treated with BrdU and analyzed as in Fig 3.6.
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3.3.5 T-bethi progenitors give rise to Eomeshi progeny.
To trace lineage relationships between these subpopulations of exhausted CD8+
T cells, we first used expression of PD-1 as a surrogate surface marker of T-bethi and
Eomeshi subsets together with CFSE labeling to monitor proliferation and differentiation
in vivo (Fig 3.10A,B). Following adoptive transfer to infection-matched mice, PD-1hi (Tbetlo Eomeshi) CD8+ T cells divided modestly and retained high expression of PD-1 (Fig
3.10C). In contrast, PD-1int (T-bethi Eomeslo) CD8+ T cells demonstrated enhanced in
vivo proliferation and this extensive division was associated with conversion to PD-1hi
(Fig 3.10C). Similar results were obtained using the Eomesgfp/+ reporter mouse (Fig
3.11A). Two weeks post-transfer, GFP+ CD8+ T cells maintained GFP expression while
some GFP- transitioned to GFP+ (Fig 3.11B). Thus, virus-specific CD8+ T cells appear to
convert from T-bethi to Eomeshi in a process coupled to extensive cell division. Once
generated, however, the PD-1hiEomeshiT-betlo subset had a reduced capacity to undergo
additional proliferation in vivo. To test whether Eomes was essential during the T-bethi to
Eomeshi transition, virus-specific CD8+ T cells from chronically infected Eomes+/+ and
Eomesf/f mice were treated in vitro with Tat-Cre and adoptively transferred into infectionmatched mice (Fig 3.12A). The temporal loss of Eomes led to a reduction in the
extensively divided CD8+ T cell population (Fig 3.12B), suggesting that Eomes plays a
critical role in initiating or sustaining this proliferative event.
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Figure 3.10. T-bethi Eomeslo CD8+ T cells convert to T-betlo Eomeshi CD8+ T cells.
PD-1int CD8+ T cells convert to PD-1hi CD8+ T cells during extensive proliferation. (A)
Relative expression of T-bet, Eomes, and PD-1 in Dbgp33-specific CD8+ T cells d21 post
clone 13 infection. (B) CD8+ T cells from chronically infected CD45.2 mice were isolated
d22 p.i., sorted based on PD-1 expression, CFSE-labeled, and transferred into infectionmatched CD45.1 recipient mice. PD-1 expression and CFSE dilution were assessed 7
days post-transfer. (C) Plots display PD-1 expression versus CFSE dilution of donor
gp276-specific CD8+ T cells. Numbers indicate frequencies of gated populations.
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Figure 3.11. T-bethi Eomeslo CD8+ T cells convert to T-betlo Eomeshi CD8+ T cells.
GFP- CD8+ T cells from Eomesgfp/+ mice convert to GFP+ CD8+ T cells. (A) CD8+ T cells
from chronically infected Eomesgfp/+ mice were isolated d15 p.i., sorted based on GFP
expression, and transferred into infection-matched CD45.1 recipient mice. (B) Plots
display GFP expression (open) in donor gp276-specific CD8+ T cells 2 weeks posttransfer. Numbers indicate frequencies of gated populations.
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Figure 3.12. Eomes regulates the initiation or continuation of extensive CD8+ T cell
proliferation. (A) CD8+ T cells from chronically infected Eomes+/+ or Eomesf/f mice were
isolated d15 p.i., treated with Tat-Cre in vitro, CFSE-labeled, and transferred into
infection-matched CD45.1 recipient mice. Two weeks post-transfer, virus-specific CD8+
T cells were analyzed for CFSE dilution. (B) Plots display Eomes and PD-1 expression
and CFSE dilution in donor gp276-specific CD8+ T cells. Numbers indicate frequencies
of gated populations.
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3.3.6 Loss of T-bet or Eomes leads to loss of the CD8+ T cell response and impaired
viral control.
The absence of T-bet impedes the control of chronic viral infection, presumably
due to a shift towards more exhausted CD8+ T cells (Kao et al., 2011). In light of the
reduced features of exhaustion when Eomes was deleted (Fig 3.4, 3.5), we tested
whether eliminating Eomes would improve control of chronic viral infection. In the
absence of T-bet or Eomes, however, virus-specific CD8+ T cells could neither maintain
the antiviral response (Fig 3.13A, B) nor limit viral replication (Fig 3.13C, D). Since each
subpopulation failed to independently sustain an effective antiviral response, it was
possible that the T-bet- and Eomes-dependent subsets might contribute distinct
functions and cooperate to achieve viral control. To test this possibility, mixed chimeras
containing both Eomes cKO and T-bet KO bone marrow together were examined.
Combination of Eomes cKO (T-bethi) and T-bet KO (Eomeshi) exhausted CD8+ T cells,
however, did not improve viral control over either subset alone (Fig 3.13E). These data
suggest that the major factor sustaining virus-specific CD8+ T cell responses and limiting
viral replication during chronic infection is not independent functional attributes of T-bethi
and Eomeshi CD8+ T cells, but rather the lineage relationship between these
subpopulations.
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Figure 3.13. Deletion of T-bet or Eomes leads to impaired maintenance of the CD8+
T cell response and loss of viral control. (A) Longitudinal frequency of gp33-specific
CD8+ T cells in the blood of infected mice. (B) Total gp276-specific CD8+ T cells in the
spleens of infected mice at d30 p.i. (*p<0.05; Unpaired t test) (C) Longitudinal viral load
in the serum of infected mice. (D) Viral load in the kidney at d90 p.i. (E) Viral load in
kidneys of bone marrow (BM) chimeras transplanted with WT, TKO, EKO, or TKO and
EKO BM at d90 p.i. (*p<0.05, **p<0.01; Mann Whitney)
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3.3.7 Antigen drives the differentiation from T-bethi precursors to Eomeshi progeny.
Persisting antigen appears to be essential for converting T-bethi precursors into
the more terminal Eomeshi progeny. Compared to cells adoptively transferred into a WT
infection, transfer into mice chronically infected a variant of LCMV containing an epitopedestroying mutation at position 35 (V35A) in the gp33-41 epitope (Shin et al., 2007)
selected for Dbgp33-specific CD8+ T cells with elevated T-bet but reduced Eomes and
PD-1 expression (Fig 3.14A). If persisting antigen induces T-bethi precursors to
continually give rise to highly proliferated Eomeshi progeny, one might predict that
prolonged, uncontrolled viral replication could lead to an eventual depletion of the TbethiEomeslo precursor population. To test this possibility, CD4+ T cells were transiently
depleted during LCMV clone 13 infection, a treatment that leads to lifelong high viral load
(Matloubian et al., 1994). Sustained high viral loads caused an erosion of the in vivo
proliferation of the Eomeshi subset and loss of T-bethi precursors over time (Fig 3.14BD), suggesting a progressive imbalance of T-bethi to Eomeshi lineage repopulation.
3.3.8 Antigen drives the differentiation of T-bethi precursors to Eomeshi progeny during
hepatitis C infection.
To examine whether years of chronic viral infection strain CD8+ T cell renewal by
continuous depletion of the T-bethi Eomeslo precursor pool, we examined human
subjects infected with hepatitis C virus (HCV). While 20-30% of HCV infections
spontaneously resolve, most untreated patients experience a high viral burden for many
years (Micallef et al., 2006). Over time, patients with uncontrolled viral replication have a
gradual loss of systemic CD8+ T cell responses with an associated accumulation of
highly exhausted T cells in the liver (Kasprowicz et al., 2008; Lechner et al., 2000;
McMahan et al., 2010; Nakamoto et al., 2008), consistent with a dysregulated balance
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between self-renewal and terminal differentiation. We therefore examined whether Tbethi Eomeslo precursors could be found in patients with resolved versus chronic HCV
infection and whether T-betlo Eomeshi progeny accumulated in patients with active viral
replication (Fig 3.15A). While HCV-specific CD8+ T cells in the blood displayed a trend
toward higher Eomes expression in chronically infected subjects, there was equivalent
T-bet expression in systemic responses from resolved or chronic infection (Fig 3.15B).
In contrast, at the site of viral replication, there was substantial accrual of Eomeshi HCVspecific CD8+ T cells and a relative depletion of the T-bethi subset during chronic
infection compared to resolved infection (Fig 3.15B). Consistent with the observations in
mice, chronic HCV infection is associated with few T-bethi precursors and a concurrent
accumulation of Eomeshi terminal progeny.
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Figure 3.14. Persistent antigen may progressively deplete the T-bethi Eomeslo CD8+
T precursor pool. (A) CD8+ T cells from infected mice were isolated at d8 p.i. and
transferred to mice infected with either WT (shaded) or V35A (open) clone 13. Plots
display T-bet, Eomes, and PD-1 expression in Dbgp33-specific CD8+ T cells in the
presence (shaded) or absence (open) of antigen. (B) Eomes and PD-1 expression
versus BrdU incorporation in Dbgp276-specific CD8+ T cells from WT mice infected with
clone 13 with or without CD4 depletion. (C) Quantification of BrdU incorporation in (B).
(D) Total T-bethi gp33-specific CD8+ T cells were assessed at indicated time-points in the
spleens of chronically infected WT mice with or without CD4+ T cell depletion.
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Figure 3.15. Antigen drives the differentiation of T-bethi precursors to Eomeshi
progeny during hepatitis C infection. (A) T-bet, Eomes, and PD-1 expression in
intrahepatic HCV-specific CD8+ T cells for resolved and chronic infections. (B)
Frequency of Eomeshi and T-bethi HCV-specific CD8+ T cells in the blood and liver of
resolved and chronic infections.
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3.4 Discussion:
Memory CD8+ T cells generated after acutely resolved infection or successful
vaccination are quiescent, but capable of self-renewal and production of differentiated
effector progeny upon re-infection (Ciocca et al., 2012; Wherry et al., 2003b). In contrast,
exhausted CD8+ T cells during chronic infections are continually activated by persisting
antigen and undergo prolonged, extensive division (Casazza et al., 2001; Shin et al.,
2007; Wherry et al., 2004). How the regenerative capacity of these cells develops and
why it ultimately fails in pathological chronic infections has been unclear. Collectively,
these studies suggest that, in the face of persisting antigen, virus-specific CD8+ T cells
employ two homologous T-box transcription factors to maintain long-lasting antiviral
immunity. This maintenance parallels progenitor-progeny dynamics of cells in other
tissues organized according to proliferative hierarchies. In virus-specific CD8+ T cells, Tbet preserves the less exhausted T-bethi Eomeslo precursor population that undergoes
low rates of proliferation. In contrast, Eomes supports the more terminally exhausted Tbetlo Eomeshi population that has experienced extensive division, but has lost further
proliferative potential. While unable to fully eradicate the virus, these two cell subsets act
together to maintain a durable and partially effective CD8+ T cell response during chronic
infection.
Other extracellular signals have also been reported to be essential for
maintenance of antiviral CD8+ T cell responses during chronic infection. For example, IL21 helps to preserve CD8+ T cell responses during chronic infection, presumably as one
component of CD4+ T cell help (Elsaesser et al., 2009; Frohlich et al., 2009; Yi et al.,
2009). Loss of IL-21 receptor signaling leads to a gradual loss of antiviral CD8+ T cell
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responses (Elsaesser et al., 2009; Frohlich et al., 2009; Yi et al., 2009), however
whether this is a uniform loss of the total population or a preferential loss of either the Tbethi or Eomeshi sub-populations is not known. It is possible that IL-21 is an essential
survival cytokine to sustain either the T-bethi or Eomeshi pools. Alternatively, IL-21 could
provide an important signal to enhance the proliferation of the transit amplifying cell that
will repopulate the Eomeshi pool. Although this question has not been fully explored,
reduced BrdU incorporation and PD-1 expression early post infection in IL-21R KO cells
from WT and IL-21R KO mixed bone marrow chimeras suggests that the Eomeshi
population may be preferentially lost without IL-21 signaling (Frohlich et al., 2009). This
suggests that IL-21 may provide proliferative signals to the transit amplifying cell or
survival signals to the terminal Eomeshi population. This avenue of investigation could
prove fruitful in understanding how extracellular cues help maintain antiviral CD8+ T cell
responses, in particular if IL-21 is an important mechanism of CD4+ T cell help.
Despite functional impairment, exhausted CD8+ T cells are not inert. Rather,
these cells continually constrain viral replication and/or drive viral epitope escape
(Wherry, 2011). Design of interventions that would enhance CD8+ T cell responses to
chronic viral infections or malignancy is limited by an incomplete understanding of CD8+
T cell population dynamics. Such treatments could augment the virus-specific population
by either (1) expanding the T-bethi precursor population, (2) improving the expansion
properties of the transient amplifying population converting from a T-bethi to an Eomeshi
state, or (3) protecting the terminally exhausted Eomeshi population from cell death.
Several therapies, however, have already been observed to expand the anti-viral CD8+ T
cell population (Barber et al., 2006; Brooks et al., 2006; Ejrnaes et al., 2006; Pellegrini et
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al., 2011). The most prominent of these is blockade of inhibitory receptor pathways, in
particular the PD-1 pathway (Wherry, 2011).
While one might predict blockade of the PD-1 pathway would increase CD8+ T
cell numbers by rescuing terminally exhausted CD8+ T cells, recent evidence instead
suggests that PD-1 blockade preferentially affects either the T-bethi precursor population
or a cell arising thereof. Examination of the effects of PD-1 blockade on exhausted CD8+
T cells separated by PD-1 expression demonstrated that PD-1 blockade has little to no
impact on the properties of pre-formed PD-1hi (Eomeshi) progeny, but dramatically
improves the ability of PD-1int (T-bethi) precursors to expand and exert anti-pathogen
activities (Blackburn et al., 2008). The benefits of PD-1 blockade could act directly on Tbethi cells and expand the precursor population, leading to a greater generation of
Eomeshi progeny. Alternatively, PD-1 blockade may act to augment the amplification
phase as T-bethi progenitors expand and differentiate into Eomeshi progeny. Determining
which of these two processes may be the dominant effect of PD-1 blockade would
suggest whether a short course of treatment would lead to a lasting effect on the CD8+ T
cell response by permanently augmenting the progenitor population or only transiently
boost the generation of antiviral progeny during the treatment period.
Several investigators have also begun to observe opportunities in manipulating
multiple inhibitory and costimulatory pathways simultaneously (Blackburn et al., 2009;
Butler et al., 2011; Jin et al., 2010; Matsuzaki et al., 2010; McMahan et al., 2010;
Nakamoto et al., 2009; Raziorrouh et al., 2010; Sakuishi et al., 2010; Vezys et al., 2011;
Woo et al., 2011; Zhou et al., 2011). However, not all interventions lead to a lasting
improvement of the CD8+ T cell response. For example, coupling of PD-1 blockade to
strong 41BB co-stimulation led to a dramatic, yet transient, augmentation of the CD8+ T
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cell response (Vezys et al., 2011). The large CD8+ T cell contraction after therapy could
be due to a temporary loss of the transient amplifying population. Alternatively, the
strong 41BB stimulus may have led to depletion of the T-bethi precursor population. This
depletion would likely have detrimental consequences with regard to long-term viral
control. Thus, while manipulation of inhibitory and costimulatory pathways may
effectively expand the anti-viral CD8+ T cell population, care may be required to avoid
unbalancing this dynamic process.
A second question is how the T-bethi precursor population remains dormant
despite the abundance of antigen present during a chronic viral infection. One possibility
is that T-bethi precursors occupy specialized antigen-poor sites, preventing antigendriven activation, proliferation, and differentiation. Alternatively T-bethi precursors may
cell-intrinsically reduce T cell receptor signaling, entering a state of antigen ignorance. In
either case, lack of antigen-driven activation may be an essential component to
maintaining the T-bethi precursor population.
Consistent with this hypothesis and in contrast to exhausted CD8+ T cells,
memory CD8+ T cells extensively proliferate when transferred into a chronic viral
infection and do not appear to preserve an undivided precursor population. Furthermore,
recent work has demonstrated that a small population of memory CD8+ T cells is unable
to sustain a prolonged anti-viral response (West et al., 2011). Thus, if present in
sufficient quantities memory CD8+ T cells are effectively programmed to protect the host
in the acute phase of challenge; however, if the viral challenge cannot be contained and
establishes a chronic infection, memory CD8+ T cells may not contain the optimal
transcriptional programming to adapt to high levels of persistent antigen.
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The inability of memory CD8+ T cells to sustain an anti-viral response to a
chronic infection may have implications for vaccine development. Vaccines have
historically achieved efficacy through preventing productive infections. However, chronic
viral infections such as HIV and HCV have eluded such vaccine strategies. Moreover, as
noted above, failure to limit viral replication may lead to loss of a vaccine-induced CD8+
T cell population, rendering the host in a worse state than unvaccinated individuals.
Recent investigations, however, may have provided an alternative vaccine strategy.
Using a CMV-based vector for SIV vaccination, Hansen and colleagues elicited immune
responses that did not prevent SIV infection, but instead quickly limited viral replication
(Hansen et al., 2011). While SIV was not immediately eliminated, brief spikes in serum
viral load occurred with reduced frequency over time, suggesting a prolonged and active
CD8+ T cell response that progressively controlled viral replication. Many differences
exist between the CMV-based platform and more common prime-boost regimes.
However, delivery of persistent antigen by the CMV-based vector may induce the
formation of a T-bethi CD8+ T cell precursor pool that resists antigen-induced activation
and proliferation, allowing CD8+ T cells to generate a sustained and effective anti-viral
response. Thus, in addition to strategies that may elicit sterilizing immunity, vaccine
platforms that employ persistent antigen may offer a second approach to combat chronic
viral infections.
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CHAPTER 4: Concluding remarks and future directions
4.1 Overview of Results.
Eomes has been reported to direct the differentiation of NK (Gordon et al., 2012)
and CD8+ T cells (Banerjee et al., 2010; Intlekofer et al., 2008; Intlekofer et al., 2005).
What have remained less clear, however, are the specific features of the CD8+ T cell
response that correlate with Eomes expression. In Chapter 2 of this thesis, Eomes
expression was not associated with a differential cytotoxic potential of in vivo generated
effector cells. Nevertheless, Eomes expression was associated with enhanced basal
homeostatic proliferation and Eomes protein was essential to maintain this homeostatic
division, a finding previously suggested (Banerjee et al., 2010; Intlekofer et al., 2005) but
which had yet to be formally demonstrated. Thus, the description and characterization of
the Eomesgfp/+ mouse has provided a solid foundation for exploration into the biology of
Eomesodermin in both Chapters 2 & 3. This reagent may still provide opportunities to
further discovery (discussed below).
In CD8+ T cell responses to acutely resolved infections, Eomes supports the
long-lived, self-renewing memory population. In contrast, during the course of a chronic
viral infection, Eomes was found in Chapter 3 to support the generation and
maintenance of a population of short-lived, terminally differentiated cells. Eomes helps to
maintain this antiviral population by supporting the extensive cell division necessary to
repeatedly repopulate this terminal pool from T-bethi precursors. Thus, depending on the
duration of infection, T-box transcription factors appear to support either a long-lived
progenitor pool or a terminally differentiated antiviral population.
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The critical balance between progenitors and progeny in exhausted CD8+ T cells
indicates a vital role for proper regulation of antiviral lymphocyte dynamics during
chronic infections. The ability to define and monitor progenitors and progeny over time
might provide an opportunity to predict the collapse of long-term control of chronic
infections. Finally, delineating the molecular coordination of this process provides a
framework for prophylactic or therapeutic strategies to improve the durability and
regenerative capacity of antiviral T cells during persisting infections.

4.2 Distinct or identical activity of T-box factors in response to acutely resolved vs
chronic viral infection.
Previous work has associated Eomes transcriptional activity with highly functional
CD8+ T cell responses, either through the acquisition of effector functions (Intlekofer et
al., 2008; Pearce et al., 2003) or through maintaining the long-lived and self-renewing
central memory CD8+ T cell population after an acutely resolved infection (Banerjee et
al., 2010; Intlekofer et al., 2005). Alternatively, T-bet activity is often associated with
terminal differentiation (Intlekofer et al., 2007; Joshi et al., 2007). Thus, the findings in
Chapter 3 that Eomes is highly expressed in more terminally differentiated and
dysfunctional CD8+ T cells during chronic infection, while T-bet supports a lessdifferentiated precursor population, may appear paradoxical. One possibility is that
distinct cofactors arise in acute versus chronic infections and differentially modulate the
transcriptional activity of T-box factors. Consistent with this hypothesis, Bcl6 appears to
convert T-bet from a transcriptional activator to a repressor, at least for a select set of
target genes (Oestreich et al., 2011). The pathways and functions that these T-box
factors activate or repress may display a large degree of context-dependent variation.
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An alternate or complimentary hypothesis, however, is that Eomes may regulate
a common pathway that is shared across multiple cell types and environmental stimuli.
During embryonic development, Eomes regulates both trophoblast formation (Russ et
al., 2000) and neuronal development (Arnold et al., 2008). In the immune system,
Eomes appears to regulate the maturation of NK cells (Gordon et al., 2012), selfrenewing central memory CD8+ T cells (Banerjee et al., 2010), and aberrant doublenegative T cells in the setting of autoimmune Autoimmune Lymphoproliferative
Syndrome (ALPS) (Kinjyo et al., 2010). One consistent feature in these disparate
settings is that Eomes is expressed in cells undergoing proliferation. Furthermore,
deletion of Eomes leads to the loss of this proliferative population (Arnold et al., 2008;
Banerjee et al., 2010; Gordon et al., 2012; Kinjyo et al., 2010; Russ et al., 2000). Thus,
Eomes may activate specific pathways – DNA damage responses, metabolic changes,
etc. – that are essential for maintaining cells during these periods of proliferation.
Understanding how Eomes might regulate cell proliferation may lead to novel or
improved therapies directed at eliminating unwanted populations such as in ALPS or
bolstering desired populations such as in anti-viral or anti-tumor CD8+ T cell responses.

4.3 Use of a fluorescent reporter to identify transcriptional targets and regulators
of Eomesodermin.
Identification of the transcriptional targets of Eomes during acute and chronic
infection would begin to address whether these T-box factors have conserved activity
with situational manifestations or context dependent activity. Two approaches could
prove to be fruitful in addressing this question. First, chromatin immunoprecipitation of
Eomes from antiviral CD8+ T cells at different stages of differentiation (effector, memory,
and exhausted) could determine whether Eomes may regulate the same or distinct gene
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sets in response to acutely resolved or chronic infections. While Eomes might bind to
and thereby regulate distinct gene sets in acutely resolved and chronic viral infections,
this differential binding could simply be a result of chromatin accessibility, not differential
targeting. Consistent with this hypothesis, T-box transcription factors appear to have
equal binding of consensus sequences regardless of context. For example, T-box
factors from separate subfamilies can bind the same set of target genes (Lewis et al.,
2007), suggesting that association with potentially distinct cofactors does not limit
binding to transcriptional targets. Similarly, T-bet has been reported to bind the same set
of target genes in a variety of lymphocytes regardless of transcriptional activity at such
targets (Beima et al., 2006). These findings suggest that the context dependent
cofactors for T-box factors (such as those that vary between lymphocyte lineages) may
not direct binding to distinct transcriptional targets, but rather may modulate the
transcriptional activity of T-box targets. Thus, while promising, chromatin
immunoprecipitation may be only one or several technologies that need to be employed
to determine how T-box factors have context dependent functions.
A complimentary approach to investigate the differential activity of Eomes in
acutely resolved versus chronic infections would employ the Eomesgfp/+ reporter mouse
characterized in Chapter 2. Whole genome expression profiling has been used to define
the transcriptional signature at different stages of cellular differentiation (Ivanova et al.,
2002; Novershtern et al., 2011; Phillips et al., 2000; Wherry et al., 2007). In a similar
manner, gene expression analysis of GFP+ and GFP- CD8+ T cells from Eomesgfp/fl mice
with or without a CD4-Cre could not only define the transcriptional program associated
with Eomes expression but also begin to differentiate the transcriptional program

80

activated upstream or in parallel to Eomes expression from the set of genes that are
regulated downstream of Eomes.
Specifically, the set of differentially expressed genes between GFP+ and GFPEomesgfp/+ CD8+ T cells would comprise the transcriptional network associated with
Eomes expression, however, this gene set is a combination of genes that are activated
upstream or in parallel to Eomes transcription and genes that are directly regulated or
downstream of Eomes transcriptional activity. Transcriptional profiling of GFP+ and GFPEomesgfp/- CD8+ T cells would assist in disaggregating these two gene sets. The
differentially expressed genes between GFP+ and GFP- Eomesgfp/- CD8+ T cells would
define the gene set activated upstream and in parallel to Eomes activation. In contrast,
the differentially expressed gene set between GFP+ CD8+ T cells with or without Eomes
protein would define the transcriptional program downstream of Eomes transcriptional
activity. Disaggregating these two gene sets could illuminate new opportunities for
therapeutic intervention in settings where Eomes activity may need to be enhanced,
such as CD8+ T cell responses to viral infection (Banerjee et al., 2010; Intlekofer et al.,
2008; Intlekofer et al., 2005), or reduced, such as double negative T cells in ALPS
(Kinjyo et al., 2010).

4.4 Senescence versus Exhaustion: distinct or overlapping processes?
Using the LCMV model of chronic viral infection, T cell exhaustion was defined
by impaired antiviral responses, including reduced proliferation and effector functions
(Zajac et al., 1998). The development of exhaustion is dependent on the persistence of
antigen (Mueller and Ahmed, 2009) and displays a gradient of dysfunction that
correlates with the length or intensity of antigen exposure (Wherry et al., 2003a). In
addition to prolonged antigen exposure, immunoregulation is a second fundamental
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component that limits effective and functional responses. As mentioned in Chapter 1,
specific immunoregulatory cytokines, such as IL-10 (Brooks et al., 2008; Brooks et al.,
2006) or TGF-beta (Tinoco et al., 2009) have been reported to limit CD8+ T cell
responses and effective viral clearance. Similarly, expression of inhibitory receptors are
thought to impair optimal antiviral immunity, since enhanced expression of inhibitory
receptors correlates with reduced functionality and blockade of these signaling pathways
leads to improved T cell function. While the examination and potential reversal of CD8+ T
cell exhaustion has largely focused on the loss of effector functions, the revival of
proliferative capacity is a prominent feature of restored antiviral responses. Whether
these two features are intertwined and causally linked is unclear.
Senescence is the loss of further proliferative potential due to either telomere
shortening or the DNA damage response to irreparable DNA, which often develops after
a period of extensive proliferation (Akbar and Henson, 2011). Replicative senescence of
CD8+ T cells is associated with aging, leading to poor antiviral responses in aged mice
or humans (Akbar and Henson, 2011; Decman et al., 2010). These responses are best
characterized by a reduced expansion in response to antigenic stimuli (Akbar and
Henson, 2011; Decman et al., 2010), however, they also contain other dysfunctional
features, including increased inhibitory receptor expression (Decman et al., 2012). Thus,
senescence of CD8+ T cells share a number a features with T cell exhaustion, prompting
speculation whether the two processes overlap.
Consistent with this hypothesis, previous analyses of CD8+ T cells from HIVinfected subjects revealed an elevated proliferative history as measured by T cell
Receptor Excision Circles (Brenchley et al., 2003), markers associated with shortened
telomeres (Brenchley et al., 2003), and elevated incorporation of deuterated glucose into
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DNA (Hellerstein et al., 1999; Hellerstein et al., 2003; Ladell et al., 2008; McCune et al.,
2000; Mohri et al., 2001). In addition, HIV-specific CD8+ T cells have reduced
proliferative potential in vitro after antigenic stimulation (Brenchley et al., 2003). Lastly,
the transcriptional profiles of age-associated senescence and exhaustion share a similar
transcriptional signature (Decman et al., 2012).
The data presented in Chapter 3 contextualize the apparent overlap between
replicative senescence and functional exhaustion. During chronic infection, Eomes
expression defines a population of CD8+ T cells that display reduced effector function,
increased inhibitory receptor expression, extensive replicative history, and reduced
proliferative potential. This Eomeshi population constitutes the majority of the antiviral
response during periods of high viral load when dysfunctional responses are most
apparent. Thus, previous analysis of virus-specific CD8+ T cell populations during
chronic infection may have principally described the Eomeshi, more terminally
differentiated and senescent population, and likely overlooked the proliferative potential
of the T-bethi precursor pool.
Whether inhibitory receptor expression increases and effector functions decrease
as a direct correlate of division history in the Eomeshi pool remains to be determined.
Nevertheless, it is likely that extensive division history in both exhaustion and
senescence correlates with reduced proliferative potential and effector functions.
Whether this process is controlled by the same molecular mechanisms remains to be
explored.
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4.5 Divergent development of memory and exhaustion.
In Chapter 3, a long-lived T-bethi progenitor pool was determined to sustain the
antiviral CD8+ T cell response. How this progenitor pool develops is unclear. What has
been demonstrated, however, is the progressive divergence of memory and exhaustion.
CD8+ T cells appear to have equal potential for memory or exhaustion early in the
antiviral response (day 8 post-infection) depending on the resolution or persistence of
infection. This apparent plasticity is restricted to the memory precursor population, as
terminal effectors do not persist in the face of persistent antigen (Angelosanto et al.,
2012); however, it remains to be determined whether (1) memory precursors are
homogenously receptive to instructive signals associated with resolution or persistence
of viral infection or (2) subpopulations of memory precursors are pre-programmed for
these two distinct outcomes and respond to selective signals that result from resolution
or persistence of infection.

4.6 Similarities and differences between recall responses of memory and
maintenance of exhaustion.
A major question arising from this work is whether the continual repopulation of
the Eomeshi pool from T-bethi precursors parallels recall responses by memory cells
against re-exposure to cognate antigen. In the most fundamental framework, these two
processes are quite similar. In both cases, in response to antigenic stimulation, a longlived precursor population contains the capacity to differentiate, proliferate, and
(re)generate a larger, short-lived population. In addition, a lengthy and repeated
repopulation of the short-lived pool drains the renewal and proliferative capacity of the
long-lived population and eventually impairs future proliferative events. Thus,
conceptually, maintenance of exhausted CD8+ T cell responses by the T-bethi precursor
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pool parallels the essential function of long-lived memory CD8+ T cells in providing
lifelong immunity to acutely resolved infections.
Previous reports (West et al., 2011) in conjunction with the data presented in
Chapter 3, however, suggest important differences between memory CD8+ T cells and
the T-bethi precursor population during chronic infection. In particular, the relative
responsiveness to antigen as measured by the extent of subsequent proliferation is
markedly distinct between these two populations. In the presence of a high antigen
burden during chronic infection, a small percentage of T-bethi precursors intermittently
give rise to extensively divided Eomeshi progeny. While a similar phenomenon appears
to occur with memory CD8+ T cells after a small and relatively transient encounter with
antigen (Ciocca et al., 2012), memory cells transferred into a chronic infection almost
uniformly proliferate extensively and display little renewal behavior. Consistent with
impaired renewal of memory CD8+ T cells in the context of prolonged high antigen
exposure, memory CD8+ T cells appear incapable of sustaining an antiviral response
during a chronic viral infection when viral control is not rapidly achieved (West et al.,
2011). Thus, the T-bethi precursor population displays a resistance to antigen-induced
activation, proliferation, and differentiation that may be essential to maintaining an
antiviral response during chronic infection. The distinctions between these two types of
long-lived, precursor populations may provide important avenues to prophylactically or
therapeutically intervene in one process without altering the other.
What determines this relative “antigen ignorance” in T-bethi precursors during
chronic infection is not well understood. One possibility is that these precursors occupy
select niches in the immune compartment that do not efficiently or adequately present
viral antigens, thus providing a cell-extrinsic method to preserve antigen ignorance. A
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second, cell-intrinsic mechanism for antigen ignorance could be down modulation of
TCR-signaling pathways. While this second mechanism may be more appealing, how
this would occur is unclear. Although inhibitory receptors are likely candidates to temper
TCR signaling in the T-bethi population, these receptors are more highly expressed on
the Eomeshi population than the T-bethi population. Thus, alternative mechanisms for
attenuating TCR-signaling may be more likely to maintain the state of relative antigen
ignorance of the T-bethi population. For example, the components of TCR-signaling
pathways may be differentially expressed or differentially regulated between precursors
and progeny. Alternatively, the distinct transcriptional status of these two populations
may lead to distinct transcriptional responses to TCR signaling.
Differential responsiveness to antigen receptor signaling is not unique to
exhausted CD8+ T cells. For example, strong antigen receptor signals of developing
single positive thymocytes or immature B cells in the bone marrow lead to negative
selection and apoptosis. In contrast, once those cells exit the thymus or bone marrow
and mature into naïve T or B cells in the periphery, strong antigen receptor stimuli leads
to robust proliferation and further differentiation. How the same signaling events lead to
dramatically distinct cellular outcomes, death or proliferation, remains unresolved.
Similar to exhausted CD8+ T cells one hypothesis is that the signaling pathway
downstream of the proximal signaling events may be differentially structured, leading to
the opposing outcomes. Alternatively, the transcriptional program operating during T and
B cell development may differentially modulate the activity of the downstream
transcription factors, such as NFAT, NF-κB, and others. As a result, further exploration
into the mechanisms behind the differential responses to TCR signaling in exhausted
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CD8+ T cells may inform other scenarios of disparate reactions to antigen receptor
signals.

4.7 Does asymmetric cell division contribute to CD8+ T cell responses during
chronic viral infection?
In response to antigenic stimuli or other external cues, lymphocytes have been
proposed to undergo asymmetric cell division (ACD) to generate two daughter cells with
distinct properties and outcomes (Barnett et al., 2012; Chang et al., 2011; Chang et al.,
2007; Ciocca et al., 2012; Thaunat et al., 2012). This process is of particular relevance
to memory lymphocytes that are required to generate a large, short-lived population for
pathogen clearance while renewing the memory pool for lifelong immunity (Ciocca et al.,
2012). In a similar manner during chronic infection, T-bethi precursors delineated in
Chapter 3 are required to produce daughter cells that seed the Eomeshi population while
concurrently preserving the precursor pool. Whether exhausted CD8+ T cells employ
ACD to preserve T-bethi precursors while repopulating Eomeshi progeny is not known.
If ACD were one mechanism to sustain antiviral responses to chronic infections,
one would predict that T-bethi precursors would have relatively high rates of ACD to
simultaneously generate one cell the T-bethi pool while giving rise to a second transit
amplifying cell that would undergo a series of subsequent symmetric divisions that would
repopulate the Eomeshi pool. If this were the case, specific fate determinants would be
asymmetrically distributed during this process. In particular, specific transcription factors
that regulate exhausted CD8+ T cells could be differentially inherited, such as T-bet or
Eomes as well as Blimp1 (Shin et al., 2009), BATF (Quigley et al., 2010), STAT3 (Siegel
et al., 2011), NFAT (Agnellini et al., 2007), or a number of other factors upregulated in
exhausted CD8+ T cells (Wherry et al., 2007).
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4.8 Summary
When the work described here was initiated, the transcriptional regulation and
population dynamics of CD8+ T cell responses to chronic viral infections were not well
understood. The identification of precursors and progeny in the CD8+ T cell response
should provide a framework for future investigations into disease progression and
immunologic manipulation during chronic infection. Even so, the work presented here
may also emphasize how investigators should use the caution before defining a
transcriptional program by only one or two transcription factors, as T-bet and Eomes, like
many other transcription factors, appear to act in exquisitely context dependent
manners.
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